Next Article in Journal
Osteopontin Preconditioning Improves the Regenerative Effects of Mesenchymal Stem Cells In Vitro but Not Their Therapeutic Efficacy Following Hypoxia-Ischemia in Mice
Previous Article in Journal
Valeric Acid: A Gut-Derived Metabolite as a Potential Epigenetic Modulator of Neuroinflammation in the Gut–Brain Axis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Enamel Maturation as a Systems Physiology: Ion Transport and Pi Flux

Center for Craniofacial Molecular Biology, Department of Biomedical Sciences, Herman Ostrow School of Dentistry of USC, University of Southern California, Los Angeles, CA 90089, USA
*
Author to whom correspondence should be addressed.
Cells 2025, 14(22), 1821; https://doi.org/10.3390/cells14221821
Submission received: 21 October 2025 / Revised: 14 November 2025 / Accepted: 17 November 2025 / Published: 20 November 2025

Abstract

Dental enamel, the final product of amelogenesis, is a highly mineralized bioceramic that becomes acellular and non-regenerating after tooth eruption. This paper reviews literature that explores inorganic phosphate (Pi) transport during the process of enamel formation or amelogenesis. Evidence from transcriptomics, immunolocalization, and physiology implicates ameloblast-specific sodium-dependent Pi uptake by type III sodium–phosphate cotransporters SLC20A1 (PiT1) and SLC20A2 (PiT2), and by type IIb sodium–phosphate cotransporter SLC34A2 (NaPi-IIb) with stage-specific basal (proximal) or apical (distal) enrichment, and pH-dependent expression. Controlled Pi efflux to the enamel space has been partly attributed to xenotropic and polytropic retrovirus receptor (XPR1) mediated Pi export during maturation-stage amelogenesis. These amelogenesis-specific Pi fluxes operate within a polarized cellular framework in which Ca2+ delivery and extrusion, together with bicarbonate-based buffering regulated by cystic fibrosis transmembrane conductance regulator (CFTR), Solute carrier family 26 (SLC26) exchangers, anion exchanger 2 (AE2), and electrogenic sodium bicarbonate cotransporter 1 (NBCe1), at-least partially contribute to cellular Pi activity, and neutralize protons generated as the extracellular hydroxyapatite-based enamel matures. Disruption of phosphate handling reduces crystal growth and final mineral content of enamel, and produces hypomineralized or hypomature enamel with opacities, post-eruptive breakdown, and greater caries susceptibility. This review integrates multi-modal findings to appraise established features of ameloblast Pi handling, define constraints imposed by pH control and Ca2+ transport, and identify gaps in ion transporter topology and trafficking dynamics.

1. Introduction

Dental enamel, the hardest and most mineralized tissue in the human body, is formed through a highly regulated process called amelogenesis [1]. Once enamel formation is complete and the tooth erupts, the tissue becomes acellular and incapable of regeneration, meaning that any developmental disturbance is permanently preserved in the mature enamel layer [2]. Amelogenesis proceeds in distinct stages of secretory, transition, and maturation, during which ameloblasts orchestrate extracellular matrix deposition, protein processing, and massive influx and efflux of ions necessary for hydroxyapatite crystal growth [3,4,5,6].
The transport and regulation of calcium, chloride, sodium, potassium, and magnesium in ameloblasts are well-documented, with comprehensive reviews detailing channel and transporter repertoires across secretory and maturation stages (e.g., Ca2+/Store-Operated Calcium Entry (SOCE), potassium-dependent sodium-calcium exchanger (NCKX)/sodium-calcium exchanger (NCX)/Plasma Membrane Calcium ATPase (PMCA); CFTR/AE2/NBCe1; Na+/K+-adenosine triphosphatase (NKA)/sodium/hydrogen exchanger 1 (NHE1)/K+ channels; cyclin and CBS domain divalent metal cation transport mediator 4 (CNNM4)/Transient receptor potential cation channel, subfamily M, member 7 (TRPM7)) [1,7]. By contrast, inorganic phosphate (Pi), a fundamental building block of hydroxyapatite, has historically received less focused attention in enamel biology, despite classic tracer studies showing Pi incorporation during enamel development [8,9]. Only recently has the field begun to define how ameloblasts regulate Pi uptake, distribution, and efflux. Sodium-dependent phosphate transporters SLC20A1/SLC20A2 (PiT1/PiT2) and SLC34A2 (NaPi-IIb), together with the exporter XPR1, show stage-resolved expression in the enamel organ. Recent structural work also establishes XPR1 as the dedicated mammalian phosphate exporter, refining models of Pi handling at the enamel surface [9,10,11]. These findings point to a more complex and tightly coordinated phosphate transport network than previously recognized [1,7,12]. Understanding these mechanisms is crucial, as disruptions in phosphate handling may directly interfere with mineralization, leading to structural defects in enamel.

2. Overview of Amelogenesis

Amelogenesis is the complex, highly regulated process by which dental enamel, the most mineralized and hardest tissue in the vertebrate body, is formed by specialized epithelial cells called ameloblasts [1,13,14,15]. This process is confined to the enamel organ and proceeds in concert with tooth morphogenesis, ultimately producing a non-collagenous, acellular, and avascular mineral layer that, once matured, cannot regenerate [2,14,16].
Tooth development begins with the dental lamina, a thickened band of oral epithelium that invaginates into neural crest-derived mesenchyme to form the dental placode [17,18]. Through the bud, cap, and bell stages, reciprocal epithelial–mesenchymal signaling orchestrates crown morphogenesis [19,20,21]. During the bell stage, the enamel organ differentiates into the inner enamel epithelium (precursor to ameloblasts), outer enamel epithelium, stellate reticulum, and stratum intermedium [13,22]. Inductive cues from the underlying dental mesenchyme not only trigger ameloblast differentiation but also guide the morphogenesis of the dentin-enamel junction (DEJ), which sets the blueprint for enamel thickness and shape [23].
Amelogenesis is traditionally divided into three functional stages, secretory, transition, and maturation, preceded by a pre-secretory stage [1,24,25]. Each stage is marked by distinctive morphological and molecular features that reflect changing ameloblast functions: matrix production, ion transport, and matrix removal. Some authors further subdivide these into early/late phases, but the central functional transition remains between secretion and maturation [26,27,28,29].
Because enamel formation proceeds without subsequent remodeling, any disruption, whether genetic, environmental, or systemic, can lead to permanent defects such as amelogenesis imperfecta, fluorosis, or hypomineralization [1,30]. Although ameloblasts may partially compensate for transient disturbances, fully matured enamel is irreversible and lacks intrinsic repair capacity [4,30]. A stage-specific understanding of ameloblast biology is essential not only for developmental biology but also for designing regenerative and biomimetic repair strategies.

2.1. Pre-Secretory Stage

The pre-secretory stage marks the earliest commitment of inner enamel epithelial cells to the ameloblast lineage, occurring after odontoblast differentiation and the initial deposition of predentin. This dentin matrix serves as a critical trigger for ameloblast polarization and cytodifferentiation [31,32,33,34,35,36,37]. During this phase, pre-ameloblasts elongate, reverse nuclear polarity (shifting nuclei away from the basement membrane), and reorganize their cytoskeleton. These morphological changes transform undifferentiated epithelial cells into highly polarized units capable of specialized secretion in the next stage [3,37,38,39]. This transition is driven by tightly coordinated epithelial–mesenchymal interactions. Reciprocal epithelial–mesenchymal signals, including bone morphogenetic proteins (BMPs), fibroblast growth factors (FGFs), transforming growth factor-beta (TGF-β), sonic hedgehog (Shh), and Wingless-related integration site (Wnt) ligands, activate transcriptional programs in pre-ameloblasts that initiate expression of enamel matrix genes such as Ameloblastin (AMBN), Enamelin (ENAM), and Amelogenin X-linked (AMELX). These signals initiate low-level expression of AMBN, ENAM, and AMELX (with incipient Matrix metallopeptidase 20 (MMP20)) at the pre-secretory stage that is detectable at mRNA and protein levels but below the robust expression characteristic of the ensuing secretory stage [1,40,41,42,43,44,45,46].
AMBN protein is particularly prominent in the pre-secretory and early secretory stages, functioning in cell–matrix adhesion to maintain contact between newly polarized ameloblasts and the forming dentin matrix [13,47,48,49]. Supporting layers of the enamel organ start to assume their specialized roles. The stratum intermedium expresses alkaline phosphatase (ALPL) and other factors thought to facilitate phosphate metabolism and early ion handling, while the stellate reticulum maintains the spatial organization of the enamel organ via an extracellular matrix rich in glycosaminoglycans [1,50,51,52].
Although mineralization has not yet begun, pre-secretory ameloblasts assemble the biosynthetic machinery for secretion through expanding their rough endoplasmic reticulum and Golgi apparatus and generating secretory vesicles. By the end of this stage, the architectural and molecular groundwork is in place for large-scale matrix production (Figure 1) [25,34,37,53].

2.2. Secretory Stage

The secretory stage is the first major functional phase of enamel formation, during which ameloblasts establish the full thickness of the enamel layer and the organizational framework for its rod-interrod architecture [36,54,55,56]. Ameloblasts in mammals become tall (~70 μm), columnar, and highly polarized, extending apical projections known as Tomes’ processes. These processes secrete enamel matrix in spatially distinct domains, producing the tightly interlocking prism (rod) and interrod pattern that confers mechanical strength and resistance to crack propagation [1,5,56].
The enamel matrix at this stage is composed primarily of three proteins. Amelogenin (AMELX) (~90% of the organic matrix), which self-assembles into ~20 nm nanospheres that align hydroxyapatite ribbons and prevent lateral fusion, producing the high aspect ratio characteristic of enamel crystallites. AMBN, which sustains cell–matrix adhesion and ameloblast differentiation, ensuring precise cell positioning during secretion, and ENAM, which is essential for crystal nucleation and elongation [41,47,48,57,58,59,60]. These proteins create a scaffold that controls crystal orientation, growth, and spacing. Controlled proteolysis begins immediately with MMP20, which degrades matrix proteins in a regulated fashion to allow crystallite elongation while maintaining structural stability [61,62,63,64].
Initially, enamel is a partially mineralized, hydrated tissue with roughly equal proportions of mineral, protein, and water. Hydroxyapatite crystallites elongate along their c-axis from the dentin-enamel junction (DEJ) toward ameloblasts under near-neutral pH conditions. Evidence suggests nucleation may occur on mineralized dentin collagen fibrils at the DEJ, with enamel crystals extending outward into the protein scaffold [1,63,65,66]. Ameloblasts maintain the ionic microenvironment of the enamel space through tight apical junctions and more permeable basal junctions that allow nutrient and ion exchange with the vascularized supporting cell layers (stratum intermedium, stellate reticulum, and outer enamel epithelium). These layers are metabolically active, facilitating delivery of Ca2+, PO43−, and other ions [1,6,67,68].
Enamel secretion proceeds in circadian and longer-period rhythms, recorded as cross-striations (~4 μm/day in humans) and striae of Retzius (~7–11 days). These incremental lines provide permanent records of secretion rate and developmental stress [69,70,71,72,73,74,75]. In continuously growing teeth such as rodent incisors, stem cells at the cervical loop maintain lifelong secretory activity, whereas in humans, ameloblasts terminally differentiate, restricting enamel production to a defined developmental window [1,76,77,78,79].
Transcriptomic studies (e.g., Postnatal day 5 (PN5) mouse molars) show high expression of Amelx, Ambn, Enam, Mmp20, and regulators of vesicle trafficking, cytoskeletal organization, and cell adhesion. Ion transporters are expressed at low levels in this stage and become more functionally significant during the transition and maturation stages [29,43,80,81,82].
In summary, the secretory stage constructs the proteinaceous scaffold that determines enamel thickness, prism organization, and initial mineral framework, setting the stage for the extensive mineralization and matrix clearance that follow (Figure 1).

2.3. Transition Stage

The transition stage is a brief yet pivotal period in amelogenesis, marking the shift from matrix production to mineralization [1,4,6,36,83]. In the rat lower incisor, it spans approximately 170 μm, equivalent to about 30 to 40 ameloblast widths, but in this short distance, the enamel organ undergoes extensive structural and molecular remodeling [1,4,6,84].
Ameloblasts that were tall and columnar during the secretory stage shorten from about 70 to 40 μm and retract their Tomes’ processes. At the same time, the enamel organ collapses from its multilayered form into a condensed papillary layer that replaces the previous organization of ameloblasts, stratum intermedium, stellate reticulum, and outer enamel epithelium. This papillary layer is highly vascularized and is strategically positioned to supply calcium, phosphate, and bicarbonate to the enamel surface during the upcoming maturation phase [1,3,84,85,86,87,88,89,90].
At the transcriptomic level, there is a pronounced switch in gene expression. Enamel matrix protein genes such as Amelx, Ambn, and Enam are markedly downregulated, while genes involved in ion transport, pH regulation, and proteolysis are strongly upregulated. Kallikrein-related peptidase 4 (Klk4) becomes increasingly active, complementing residual MMP20 activity to initiate the degradation of the remaining organic matrix. Several key transporters, including Solute carrier family 24 member 4 (Slc24a4), Ae2, Cftr, Nbce1, and carbonic anhydrase II (CA II), are upregulated at this point to prepare ameloblasts for the ion-handling demands of maturation [1,80,81,87,91,92,93,94].
A distinctive feature of transition is programmed cell death in a substantial fraction of ameloblasts (≈25%), a change documented in rodent incisors and linked to stage progression [95]. Mechanistically, apoptosis in this window has been associated with calcium overload and Endoplasmic reticulum (ER) stress (including fluoride-triggered ER stress in vivo and in ameloblast models) and with Transforming Growth Factor Beta 1 (TGF-β1)/SMAD family member 2 and 3 (Smad2/3) signaling, which is upregulated during late development and influences ameloblast survival and differentiation [96,97,98,99]. It may serve as a quality control step, ensuring that only fully functional ameloblasts proceed to the maturation stage. Odontogenesis-associated phosphoprotein (ODAPH), which peaks in expression during this phase, may help stabilize ameloblast adhesion during the structural reorganization of the enamel organ [97,98,100,101,102].
Overall, the transition stage prepares the enamel organ for the high metabolic demands of maturation (Figure 1). It achieves this by reorganizing epithelial architecture, priming ion transport systems, initiating matrix clearance, and selectively retaining the cells best equipped to complete enamel mineralization.

2.4. Maturation Stage

The maturation stage is the final and most mineralization-intensive phase of amelogenesis. During this period, enamel mineral content increases from around 30 percent to more than 95 percent by weight, while water and organic material are reduced to less than 2 percent. This transformation produces the dense, highly crystalline hydroxyapatite structure that gives enamel its exceptional hardness and resistance to wear [1,6,103,104,105,106].
Ameloblasts at this stage shorten to roughly 40 μm in height and cycle between ruffle-ended and smooth-ended morphologies (Figure 1). Ruffle-ended cells have a highly folded apical border, tight junctions, and a mitochondria-rich cytoplasm, creating a sealed environment optimized for active ion transport, pH regulation, and the endocytosis of protein fragments. Smooth-ended cells, by contrast, have a less complex apical surface and looser junctions, allowing greater fluid exchange that aids in the removal of degraded proteins and the dissipation of acidic byproducts. The cyclical modulation between these morphologies is thought to be driven by local pH fluctuations in the enamel space, with acidification promoting the ruffle-ended form and alkalinization favoring the smooth-ended form [1,4,6,24,36,85,107].
KLK4 activity reaches its peak during maturation, completing the degradation of amelogenin and other residual matrix proteins. This clearance is essential to create the space needed for crystals to grow laterally, increasing in width and thickness until they form densely packed prisms. The papillary layer, established during the transition stage, continues to supply calcium, phosphate, and bicarbonate to ameloblasts, while the stratum intermedium and stellate reticulum maintain phosphate regulation and structural support [6,55,88,108,109,110,111,112].
The functional details of ion transport and acid-base regulation at these stages are discussed extensively in the next section (Ion Transport During Enamel Maturation). Together, these processes ensure that the enamel reaches its full mineral density, crystal organization, and mechanical performance, completing a process that began with the first deposition of matrix at the dentinoenamel junction.

2.5. Molecular Regulation and Signaling

Amelogenesis is controlled by a complex network of signaling pathways that operate in a stage-specific manner to direct ameloblast differentiation, cytoskeletal organization, enamel matrix secretion, ion transport, and apoptosis. These pathways mediate reciprocal communication between the dental epithelium and the underlying mesenchyme, ensuring that gene expression and cellular behavior are precisely coordinated throughout enamel development. Disruptions in these molecular signals can produce developmental enamel pathologies, including various forms of amelogenesis imperfecta (AI) [1,25,44,45,46,113].
The Wnt/Catenin beta-1 (β-catenin) pathway plays a pivotal role during early enamel development, influencing ameloblast polarization, cytoskeletal organization, and transcriptional regulation. Activation of Wnt signaling stabilizes cytoplasmic β-catenin, enabling its translocation to the nucleus, where it modulates the transcription of epithelial differentiation genes. β-catenin also functions as part of the Epithelial cadherin (E-cadherin)/β-catenin complex at adherens junctions, maintaining epithelial integrity while transmitting intracellular signals that govern ameloblast fate, elongation, and spatial organization [1,114,115,116,117,118].
TGF-β1 signaling becomes particularly important during the transition and maturation stages. Through the canonical Smad2/3 pathway, it modulates the expression of key enamel matrix genes, including AMELX, AMBN, ENAM, MMP20, and KLK4. In addition to regulating matrix gene transcription, TGF-β1 appears to promote ameloblast apoptosis during the transition stage, potentially serving as a checkpoint to eliminate cells that are damaged or improperly polarized [98,119,120,121,122,123]. This dual role, supporting both matrix production and programmed cell death, underscores the highly stage-specific function of TGF-β1 in amelogenesis.
Members of the bone morphogenetic protein family, particularly Bone morphogenetic protein 2 (BMP2) and Bone morphogenetic protein 4 (BMP4), are similarly essential for initiating ameloblast lineage commitment and sustaining enamel matrix gene expression during the secretory stage. BMP signaling interacts with TGF-β pathways through shared Smad proteins and cooperates in regulating epithelial–mesenchymal signaling networks. These interactions also influence fibroblast growth factor receptor 1 (FGFR1) expression, linking morphogen signaling to cell proliferation and differentiation [32,79,124,125,126].
Fibroblast growth factor signaling, especially through FGFR1, contributes to ameloblast proliferation, spatial organization, and cytoskeletal stability. Downstream activation of mitogen-activated protein kinase (MAPK) cascades, particularly p38 MAPK, appears to regulate polarity proteins and vesicular trafficking mechanisms necessary for the directional secretion of matrix protein [36,125,127,128,129].
Sonic hedgehog signaling is highly active during the secretory stage, regulating ameloblast proliferation, alignment, and the morphogenesis of the enamel organ. It also influences the expression of genes involved in vesicle trafficking and polarity establishment, and it interacts with Wnt and BMP pathways to fine-tune epithelial morphodynamics, particularly during cusp formation [36,46,130,131,132,133].
In addition to these canonical signaling systems, several matrix-associated proteins and transcription factors act as regulatory intermediates. Ameloblastin not only serves as a matrix protein but also acts as a signaling molecule that influences ameloblast adhesion, polarity, and actin cytoskeleton organization. The transcription factor Runt-related transcription factor 2 (RUNX2), better known for its role in osteoblast and odontoblast differentiation, also participates in enamel formation by regulating MMP20 expression and matrix remodeling. Odontogenic ameloblast-associated protein (ODAM), expressed during the transition and maturation stages, supports ameloblast attachment to the enamel surface and may modulate integrin-mediated signaling cascades [48,134,135,136,137].
Together, these pathways form an integrated regulatory network that coordinates gene expression, cell morphology, and functional activity at each stage of amelogenesis. A detailed understanding of these mechanisms not only provides insight into developmental biology but also offers potential targets for tissue engineering and the design of biomimetic strategies for enamel regeneration.

2.6. Clinical Implications and Enamel Defects

Because enamel formation is confined to a brief developmental window and depends entirely on transient ameloblast activity, any disturbance during secretion or maturation becomes permanently recorded in the tissue. Once erupted, enamel is acellular and lacks remodeling capacity, so these defects cannot be repaired [5]. The nature of the defect depends on the timing, duration, and type of insult, as well as the developmental stage affected [138]. Disturbances in matrix secretion during the secretory stage produce hypoplasia, characterized by reduced enamel volume, pits, or grooves. Disruptions during the maturation stage impair crystal growth and protein clearance, producing hypomineralized or hypomature enamel that is often chalky, porous, and mechanically weak [6,139,140,141].
Hereditary defects collectively referred to as amelogenesis imperfecta (AI) arise from pathogenic variants in genes expressed at specific stages of amelogenesis [25]. X-linked mutations in AMELX affect amelogenin, disrupting the nanosphere scaffold essential for crystal organization [59,142]. Mutations in ENAM, typically inherited in an autosomal dominant pattern, lead to hypoplastic enamel that is thin but relatively well-mineralized [143,144,145]. Loss-of-function variants in MMP20 or KLK4 interfere with protein degradation and clearance, yielding enamel with retained organic content and deficient mineral density [91,146,147,148]. Mutations in genes such as WD repeat domain 72 (WDR72), SLC24A4, and ODAPH impair vesicle trafficking, ion transport, or ameloblast adhesion, producing hypomaturation phenotypes [102,149,150,151]. In syndromic contexts, enamel defects may occur alongside other ectodermal or metabolic abnormalities, making genetic counseling appropriate [152,153].
Environmental and systemic factors can also compromise enamel development. Excessive systemic fluoride exposure during enamel maturation leads to dental fluorosis, in which altered ion transport, disturbed pH buffering, and impaired proteolysis result in opaque white lines, mottling, and, in severe cases, surface pitting and brown staining [154,155,156]. Molar-incisor hypomineralization (MIH), a common acquired condition, produces sharply demarcated opacities in permanent first molars and incisors, likely due to perinatal hypoxia, systemic illness, or other early childhood stressors affecting ameloblast function during maturation [141,157,158]. Enamel hypoplasia of environmental origin occurs when matrix secretion is prematurely halted by malnutrition, trauma, systemic disease, or localized infection, producing grooves, pits, or thinned enamel surfaces [138,159,160].
Clinically, enamel defects can compromise both function and aesthetics. Hypomineralized enamel is more susceptible to caries due to increased permeability and reduced acid resistance [161]. Exposed dentin beneath hypoplastic or fractured enamel can cause hypersensitivity [162]. Altered surface chemistry, including changes in wettability and mineral composition, can reduce the bond strength of restorative materials. Patients may also experience significant esthetic concerns, particularly when defects affect anterior teeth [163,164].
Management strategies depend on defect severity. Preventive measures include topical fluoride application to enhance surface resistance and the use of desensitizing agents to alleviate hypersensitivity [161]. For localized or moderate defects, resin-based composite restorations or microabrasion may be appropriate [163,165]. Severe generalized defects often require more extensive rehabilitation with porcelain veneers or full-coverage crowns to restore both function and appearance [166,167]. In hereditary cases, early diagnosis facilitates preventive care planning, patient education, and, when indicated, genetic counseling for affected families.
In summary, enamel defects represent the permanent record of developmental disturbances in amelogenesis. Whether arising from genetic mutations, environmental exposures, or systemic insults, these conditions underscore the importance of the molecular and physiological processes described in earlier sections. A detailed understanding of these mechanisms is essential for accurate diagnosis, effective treatment planning, and the development of preventive and regenerative approaches in dentistry.

3. Ion Transport During Enamel Maturation

Enamel maturation is the most ion-intensive phase of amelogenesis, during which hydroxyapatite (Hap) crystallites thicken rapidly and must do so within a tightly controlled ionic and acid-base milieu [1,7]. Ameloblasts meet this challenge by adopting a polarized transport program that (i) brings in Ca2+ and apically extrudes it in step with crystal growth, (ii) generates and secretes HCO3 to neutralize protons, (iii) sustains apical Cl conductance to keep anion exchange moving, and (iv) uses Na+/K+ cycling and K+ channels to provide the electrochemical work that couples these fluxes (Figure 2) [87,93,168,169,170]. Ruffle-ended ameloblasts (RA) and smooth-ended ameloblasts (SA) modulation synchronizes phases biased toward acid handling, matrix proteolysis, and crystal deposition so that growth proceeds within a narrow chemical window [1,171]. Classic in situ mapping shows alternating acidic (≈pH 5.8–6.0) and near-neutral (≈pH 7.0–7.2) bands under RA and SA cells, respectively, anchoring this functional view in direct pH measurements [172].

3.1. Integrated Regulation of Ion Transport During Enamel Maturation

Enamel ion transport is tightly coupled to maturation’s cyclical physiology through stage-dependent expression and membrane polarity. As ameloblasts shift from secretion into maturation, transporters that govern calcium flux, acid-base balance, and monovalent gradients are upregulated and become more sharply polarized [1]. For calcium handling, STIM1, ORAI1, NCX1/3, NCKX4, and plasma-membrane Ca2+-ATPases concentrate at their respective domains during maturation, paralleling heightened mineral demand and the alternation between ruffle-ended and smooth-ended forms, where ruffle-ended cells are especially engaged in apical Ca2+ extrusion and crystal thickening, and smooth-ended phases favor neutralization and resorption [173]. Dynamic relocalization is also evident in the acid-base machinery. AE2 shifts from apical in secretory cells to lateral or basolateral in maturation, and NBCe1 rises across the secretory-to-maturation transition [87,92]. At the enamel surface, CFTR is essentially confined to the apical pole of maturation-stage ameloblasts, where it assembles with SLC26 exchangers to form a bicarbonate-secreting hub precisely when the proton burden of hydroxyapatite growth is greatest [81,93]. Together, these spatial and temporal patterns underscore a single principle that transporter expression and topology track the surge in mineral accretion and the RA↔SA cycle to maintain a permissive microenvironment for crystal growth and matrix remodeling.
Ion transport supporting enamel maturation is interdependent rather than modular. Basolateral Na+/K+-ATPase builds the inward Na+ gradient and replenishes intracellular K+, and supporting layers of the enamel organ supply additional monovalent ions via NKCC1, together establishing the electrochemical and osmotic conditions at the ameloblast interface [174,175,176]. This sodium motive force sustains basolateral NBCe1-mediated bicarbonate uptake and, at the apical pole, powers the K+-dependent, Na+-coupled NCKX4 exchanger that delivers Ca2+ to the mineralization front, making K+ recycling a prerequisite for continuous Ca2+ export. In turn, Ca2+ flux feeds back on matrix chemistry: by shaping the ionic microenvironment at the ruffled border, NCKX4 promotes the acidity that optimizes KLK4 proteolysis, so impaired Ca2+ export secondarily reduces protein clearance and undermines maturation [168,177]. Monovalent ions, therefore, sit at the nexus of calcium transport and buffering, while epithelial crosstalk through NKCC1 in adjacent support cells helps maintain a steady Na+, K+, and Cl supply to the ameloblast surface throughout the ruffle-ended to smooth-ended cycle [175].
Converging genetic and experimental evidence reinforces this model. Perturbing the SOCE pathway via STIM1 or ORAI1 reduces Ca2+ uptake and produces hypomineralized, AI-like enamel, directly validating Calcium release-activated calcium channel (CRAC)-mediated entry in vivo [101,173,178]. Disabling the apical Ca2+ efflux arm through SLC24A4 loss abrogates NCKX4 function and yields severe autosomal-recessive amelogenesis imperfecta in mice and humans with protein retention and disorganized crystallites [81,151]. Compromising the bicarbonate axis through Solute carrier family 4 member 4 (SLC4A4) loss causes enamel hypoplasia and hypomineralization, with both local and systemic acid-base disturbances contributing [87,179]. Normalizing systemic pH rescues much of the defect in mice, consistent with NBCe1’s upstream role in base supply [180]. CFTR deficiency produces hypomineralized enamel in mice, with an acidified, chloride- and calcium-poor maturation matrix (pH-indicator positive). CFTR-null/ΔF508 pigs likewise show hypomineralized crowns on backscattered-electron imaging, mirroring the higher prevalence of developmental enamel defects reported in cystic fibrosis [169,181,182]. Removal of AE2 disorganizes maturation-stage ameloblasts and produces protein-rich, hypomature enamel, consistent with failed surface pH control [92,93,182]. Beyond divalent and acid-base transport, precise magnesium handling is also essential. CNNM4 loss in Jalili syndrome produces Mg-rich, hypomineralized enamel, and Cnnm4-deficient mice confirm a basolateral Mg2+ efflux role for CNNM4 [183,184]. Trpm7 perturbation yields enamel defects that converge mechanistically on reduced alkaline phosphatase activity; in TRPM7-kinase mutants, low ALP activity can be partially restored by Mg2+, consistent with the requirement of Mg2+ for Tissue-Nonspecific Alkaline Phosphatase (TNAP) catalysis [185]. Finally, systemic disruption of NKCC1 in the surrounding enamel epithelium disorganizes late-maturation ameloblasts and thins enamel despite compensatory increases in other transporters, underscoring that proper gradient generation in support tissues is integral to ameloblast function [175]. Taken together, these phenotypes confirm that enamel maturation depends on a distributed, mutually reinforcing transport network and that defects at any major node predictably collapse the pH cycles, Ca2+ delivery, and matrix turnover required for final hardening [1].

3.2. Calcium Transport

Calcium transport during enamel maturation is a polarized, stage-tuned process that links basolateral uptake to apical delivery while preserving intracellular homeostasis [1,186]. The prevailing entry pathway is SOCE, in which depletion of endoplasmic reticulum (ER) Ca2+ stores, typically following IP3 receptor activation, induces oligomerization of the ER sensors STIM1/STIM2 and gating of ORAI1 channels at the plasma membrane (Figure 2) [101,173]. These core SOCE components are robustly expressed in both secretory- and maturation-stage ameloblasts but are upregulated in the maturation stage when Ca2+ demand is higher [173]. Their function has been demonstrated in ameloblast systems using thapsigargin to empty ER stores and pharmacologic CRAC blockade to suppress the ensuing Ca2+ influx [101,173,178]. Genetic disruption corroborates this mechanism in vivo. Loss of STIM1 or ORAI1 reduces Ca2+ entry and produces AI-like enamel defects with disorganized, hypomineralized crowns, underscoring SOCE as the principal route for Ca2+ uptake into ameloblasts during both phases of amelogenesis [5,81,178,187].
Once in the cytosol, Ca2+ is buffered and partitioned to prevent toxicity while preserving vectorial transport. Cytoplasmic Ca2+-binding proteins, including calbindin-D28k, calmodulin, calretinin, and parvalbumin, limit free [Ca2+] and facilitate directed transit toward the apical pole [188,189,190,191,192]. In parallel, the ER operates as a dynamic reservoir via SERCA-mediated sequestration and luminal buffering by calreticulin, endoplasmin (HSP90B1), and ERp72. These findings have prompted an ER-assisted “transcytosis” model that complements cytosolic buffering rather than replacing it [1,173,186]. Morphological and physiological evidence support this vectorial handling as electron microscopy shows intracellular Ca2+ accumulation preceding its appearance in enamel, and Ussing-chamber measurements demonstrate a temperature-sensitive, basal-to-apical flux consistent with energy-dependent, transepithelial transport [193,194,195].
Apical extrusion of Ca2+ into the enamel matrix is mediated by an ensemble of exchangers and pumps. NCKX4 (SLC24A4), a K+-dependent Na+/Ca2+ exchanger, is sharply upregulated during maturation and concentrated at the apical membrane, positioning it as the dominant efflux pathway that supplies Ca2+ to the mineralization front. Loss-of-function variants in SLC24A4 cause autosomal-recessive amelogenesis imperfecta in humans and mice, with severely hypomineralized, protein-retentive enamel, highlighting the centrality of NCKX4 to enamel mineral delivery [1,81,168,196]. Additional capacity is provided by NCX1 and NCX3 (SLC8A1/A3), which exchange one Ca2+ for three Na+ and are localized apically and apicolaterally in both stages, and by plasma-membrane Ca2+-ATPases (PMCA; ATP2B1/ATP2B4), which use ATP to extrude Ca2+ in exchange for protons and thereby contribute to matrix acid-base balance as well as Ca2+ clearance [151,197,198,199,200,201].
Beyond bulk transport, NCKX4 exerts regulatory control over the enamel microenvironment. By shaping local ionic conditions at the ruffled border, NCKX4 promotes the acidity required for KLK4 activity. In its absence, matrix pH rises, KLK4-mediated proteolysis is impaired, and enamel proteins are retained. Restoring acidity rescues KLK4 function in vitro, establishing a mechanistic link between Ca2+ efflux and matrix processing [168].
Developmental regulation integrates these elements into the well-known RA to SA ameloblast cycle. Expression and membrane polarization of STIM1, ORAI1, NCKX4, NCX1/3, and PMCA increase during maturation, matching the surge in mineral demand. Ruffle-ended ameloblast phases, dominant during mildly acidic cycles (≈pH 6–6.2), drive apical ion transport and mineral accretion while smooth-ended phases coincide with near-neutral pH (≈pH 7.0–7.2) and favor neutralization, water efflux, and clearance of degraded matrix proteins (KLK4-dependent) [3,54,107]. Together, these data support a model in which SOCE-driven basolateral Ca2+ uptake, buffered cytosolic and ER transit, and coordinated apical export form a single, developmentally tuned pathway whose disruption at any node yields the characteristic hypomineralization of enamel pathologies (Table 1) [1,4,101,173,198].

3.3. Acid-Base Control: Bicarbonate and Chloride

Acid-base regulation in the enamel organ is a central constraint on mineralization because hydroxyapatite (Hap) crystal growth releases a substantial proton load into the matrix. If not neutralized, this acidity inhibits crystal accretion and protease function [24,107]. Ameloblasts meet this challenge with a polarized bicarbonate-chloride system that is developmentally tuned to the RA to SA cycle and operates in concert with proton pumps and Na+/H+ exchange to stabilize both extracellular and cytosolic pH (Table 1). The net effect is a tightly choreographed alternation between acidifying phases that favor crystal maturation and neutralizing phases that permit matrix clearance and renewed ion influx [6,87,92,93,168].
At the basolateral membrane, the electrogenic Na+/HCO3 cotransporter NBCe1 (SLC4A4) provides the principal route for bicarbonate entry (Figure 2). NBCe1 is strongly expressed as cells transition from secretion to maturation and is also detectable in the adjacent papillary layer, positioning the enamel epithelium to draw base from the circulation. Functional relevance is supported by Slc4a4-null models, which develop severe enamel hypoplasia and hypomineralization even without systemic acidosis, and by ameloblast-like cell systems (HAT7) that demonstrate sodium-dependent basolateral-to-apical bicarbonate transport and cytosolic alkalinization when NBCe1 is engaged. Clinical and experimental evidence thus converge on NBCe1 as a key upstream supplier of bicarbonate for enamel buffering [87,177,180,207,219].
Intracellular and extracellular carbonic anhydrases augment this basolateral supply by catalyzing rapid HCO3 generation from CO2 and H2O (Figure 2). Cytosolic CA II and CA III support intracellular production (Table 1). Secreted CA VI operates within the enamel space, and membrane-bound CA XII presents an extracellularly oriented catalytic domain at the ameloblast surface, placing enzyme activity directly at the mineralization front. The spatial deployments of these isoforms, abundant CA II at the apical ends of RA, luminal CA VI bathing the matrix, and CA XII embedded in the apical membrane, create a catalytic scaffold that sustains high-flux buffering precisely where protons are generated. CA XII is a membrane enzyme with an extracellularly oriented catalytic site in epithelia. Car12 mRNA is present in secretory ameloblasts, but definitive protein-level localization at the ameloblast surface is still pending [24,92,94,209,210,250].
Bicarbonate exits apically through a network built around the anion exchanger AE2 and chloride pathways (Table 1). AE2 mediates electroneutral Cl/HCO3 exchange and exhibits dynamic polarity: apical in secretory cells and then lateral/basolateral during maturation. Eliminating AE2 in mice produces a characteristic enamel phenotype: retained organic matrix, rapid wear, flattened ameloblasts, and failed modulation between ruffle- and smooth-ended forms, the hallmarks of pH dysregulation in the matrix [10,92,207]. These findings indicate that AE2 functions on both sides of the cell at different stages to maintain transcellular base movement and to keep the extracellular milieu within a narrow pH window compatible with mineral growth [1,88,94,219].
Chloride transport is equally integral, providing both charge balance and a conduit for coupled bicarbonate secretion. CFTR, a cAMP-regulated Cl channel, is concentrated at the apical pole of maturation-stage ameloblasts and absent from secretory cells, anchoring a stage-specific bicarbonate secretory hub [93]. CFTR assembles multiprotein complexes with SLC26 family exchangers, including SLC26A3, SLC26A4 (pendrin), SLC26A6, and SLC26A7, detected at apical and lateral domains and upregulated during maturation (Table 1). Co-immunoprecipitation demonstrates physical interactions between CFTR and SLC26A6/A7, supporting a model in which CFTR-mediated Cl flux and SLC26-mediated HCO3 exchange operate cooperatively to fine-tune the enamel surface pH during intense mineral deposition [214,251]. In vivo, Cftr-null mice and CFTR-null pigs exhibit under-mineralized, acidified enamel with irregular matrix architecture, paralleling dental manifestations in people with cystic fibrosis and underscoring CFTR’s central role in enamel pH homeostasis [169,182,216].
Additional chloride supply is coordinated across the enamel organ epithelium. Although ameloblasts lack NKCC1, this electroneutral Na+-K+-2Cl cotransporter is strongly expressed in the supporting layers (outer enamel epithelium/papillary complex, stellate reticulum, stratum intermedium) from cap through maturation (Figure 2). Loss of NKCC1 disrupts the ameloblast-papillary unit, yielding shorter late-maturation ameloblasts, reduced mineral density, and irregular enamel. In these mutants, NBCe1 and SLC26A3/A6 increase, along with connexin-43 coupling, consistent with a compensatory attempt to sustain ion and fluid flow, yet this is insufficient to normalize enamel formation. Together, NKCC1 in support cells and CFTR at the ameloblast apex establish a directional chloride pathway from the basolateral milieu to the enamel surface, enabling coupled HCO3 secretion, sustaining matrix hydration, and coordinating with the ruffle-ended/smooth-ended cycle [68,92,175,182].
Proton handling completes the circuit. Apically, vacuolar H+-ATPases are most active in ruffle-ended ameloblasts, where they acidify the enamel space to conditions favoring crystal maturation and matrix proteolysis. Basolaterally, NHE1 exchanges intracellular H+ for extracellular Na+, stabilizing cytosolic pH and supporting net base secretion when coupled to NBCe1-mediated HCO3 entry (Figure 2) [94,171,177]. Ameloblast V-ATPases are compositionally distinct from osteoclast pumps and appear enriched for B1/a4 isoforms during maturation. Notably, a3/TCIRG1 is present at low levels (detection-method dependent), and a3 mutations directly affect ameloblasts and enamel in mice [220]. These mechanisms are embedded within the morphological modulation itself: V-ATPase activity predominates during acidifying ruffle-ended phases, whereas bicarbonate transporters (NBCe1 and SLC26 family) are comparatively prominent during neutralizing smooth-ended phases. Disrupting this alternation by removing AE2 or by chemical stressors such as excess fluoride predictably yields hypomineralized, protein-retentive enamel [171,177,252].
Viewed as a whole, enamel pH control is a polarized, epithelial transport problem solved by coordinated basolateral bicarbonate uptake and cytosolic generation, apical bicarbonate secretion through AE2-CFTR-SLC26 assemblies, targeted proton extrusion, and continuous stabilization of intracellular pH by NHE1 (Table 1). The system’s phase-locked operation with ameloblast morphology ensures that the enamel surface alternates between acidified states that support crystal thickening and neutralized states that allow matrix clearance and renewed ion entry. When any component of this network is compromised, such as NBCe1 or AE2 loss, CFTR deficiency, diminished chloride supply from NKCC1, or stressors that derail modulation, the result is the same: failure to maintain the enamel microenvironment, with consequent hypomineralization and structural fragility [6,92,175,253].

3.4. Sodium and Potassium Handling

Sodium and potassium handling in the enamel organ underpins the electrochemical and osmotic landscape that allows ameloblasts to regulate pH, move calcium, and remodel the matrix during maturation. The system is anchored basolaterally by the Na+/K+-ATPase (NKA), which expels three Na+ in exchange for two K+ to maintain a steep inward Na+ gradient and to replenish intracellular K+ (Table 1). This gradient energizes secondary transport processes central to enamel physiology, including bicarbonate import through NBCe1 and apical Ca2+ export via the K+-dependent Na+/Ca2+ exchanger NCKX4, thereby linking monovalent ion homeostasis directly to acid-base control and mineral delivery [87,168,174,177,196]. Parallel Na+ entry through the basolateral Na+/H+ exchanger NHE1 supports cytosolic pH stability and sustains the sodium motive force that drives coupled transport. Together, these elements establish the driving forces that make transcellular base movement and Ca2+ extrusion possible during the demanding maturation stage [171,186,254].
Although ameloblasts lack notable expression of NKCC1, the Na+-K+-2Cl cotransporter is highly expressed in the outer enamel epithelium/papillary complex, stellate reticulum, and stratum intermedium, where it accumulates Na+, K+, and Cl to shape the ionic/osmotic milieu at the ameloblast interface [1,175] (Table 1). In mice, Nkcc1 ablation yields shortened late-maturation ameloblasts and thinner, roughened enamel with reduced mineral density. In these mutants, NBCe1, SLC26A3/A6, and Cx43 are upregulated as a partial compensation that nonetheless fails to normalize enamel [68,175]. Thus, support-cell transport supplies chloride and monovalent ions that ameloblasts depend on for pH regulation, fluid balance, and downstream HCO3 exchange. Monovalent-driven water flux also cycles with morphology. RA phases favor osmotic inflow (spacing/hydration), SA phases favor reabsorption and protein clearance. Sustained basolateral Na+/K+ gradients via NKA underpin this maturation-stage choreography (Figure 2) [1,6,170,176].
Potassium homeostasis in the enamel organ is set by NKA at the basolateral membrane, which maintains the inward Na+ gradient and replenishes intracellular K+ (Figure 2) [170,174]. During maturation, Kir4.2 (KCNJ15) is prominently enriched at the apical border of ruffle-ended ameloblasts, where it supports K+ recycling and stabilizes membrane potential (Not shown in the schematic). K+-Cl cotransporters (KCCs) are putative contributors to K+ efflux and coupled Cl movement that could influence matrix hydration, but their definitive localization/function in ameloblasts remains to be confirmed. Critically, intracellular K+ availability is functionally coupled to NCKX4. This apical exchanger exports 1 Ca2+ together with 1 K+ in exchange for 4 Na+, making K+ recycling/retention prerequisites for sustained Ca2+ delivery to the mineralization front. Thus, K+ handling is inseparable from the calcium economy of the ameloblast and the maintenance of the ionic microenvironment at the crystal surface [7,151,168,255,256].
These sodium and potassium cycles track the morphological modulation of ameloblasts. During RA phases, Na+ absorption and K+ efflux predominate, supporting proton secretion, matrix acidification, and proteolysis, while during smooth-ended (SA) phases, K+ reabsorption together with NBCe1- and NHE1-mediated Na+-bicarbonate and Na+-proton exchange drives neutralization and resorptive functions [4,24,168,170,172]. While direct, band-resolved in vivo K+ measurements are limited, histology/elemental mapping and transporter localization (e.g., apical Kir4.2 and NCKX4 in RA) corroborate the pattern in which matrix Na+/K+ generally decline as maturation progresses, with relative K+ enrichment during acidic intervals and clearance during neutralizing intervals. This effect becomes especially apparent when modulation or pH regulation is perturbed. The result is a phase-locked monovalent-ion program that coordinates with bicarbonate and calcium pathways to alternate between microenvironments favoring matrix degradation and those conducive to crystal growth and hardening [10,170].
Disruption of any step in this network propagates broadly. Interfering with Na+ or K+ transport distorts the driving forces for bicarbonate movement and Ca2+ export and deranges pH cycles, while loss of NKCC1 in support cells compromises the ionic scaffold needed for normal ameloblast organization and enamel thickness. Conversely, strengthening basolateral Na+/K+-ATPase-anchored gradients stabilizes downstream exchangers and pumps, preserving the tightly regulated alternation of acidification and neutralization that defines healthy enamel maturation [87,171,175,176].

3.5. Magnesium and Trace Elements

Magnesium is a minor yet indispensable determinant of enamel maturation that acts at both cellular and matrix scales. In ameloblasts, magnesium handling is governed by a small cohort of regulators that set intracellular stores and thereby influence crystal nucleation and growth. Chief among these is CNNM4, which is a basolaterally localized, sodium-coupled magnesium efflux transporter (Table 1) [184]. Loss of CNNM4 function causes Jalili syndrome and produces hypomineralized, magnesium-enriched enamel, which directly implicates tight magnesium export in normal mineral development and shows the pathological consequence of intracellular magnesium retention during amelogenesis [183,223]. Additional pathways, such as the magnesium-permeable channel TRPM7, likely contribute to cellular magnesium balance during maturation (Table 1). At the matrix level, magnesium partitions to intergranular phases, notably magnesium-stabilized amorphous calcium phosphate at crystallite boundaries, where it modulates nucleation kinetics and restrains uncontrolled lateral thickening. Together, basolateral magnesium efflux and matrix partitioning make magnesium an essential regulator. When magnesium control fails, enamel remains hypomineralized with altered crystal morphology, whereas proper regulation supports orderly crystal growth and the emergence of hard, resilient enamel [225,227,257].
A complementary axis of Mg2+ entry is provided by the divalent cation channel TRPM7, which is strongly expressed in maturation-stage ameloblasts (Figure 2). Deletion of Trpm7 produces an enamel phenotype such as marked hypomineralization with protein retention that closely resembles that of Alpl-null mice [225,227,258]. Notably, this phenotype can be partially corrected with dietary magnesium supplementation. Together with the observation that magnesium is a biochemical cofactor for ALPL, these findings support a causal chain in which TRPM7-mediated Mg2+ influx sustains ALPL activity at the mineralization front, thereby promoting local phosphate liberation and hydroxyapatite growth [232,259,260].
Elemental analyses place magnesium at about 0.2–0.25% of mature enamel by weight, and classic microprobe work shows a clear increase from the surface toward the DEJ [104,261,262]. This gradient reflects the distinct physicochemical profile of Mg2+: its smaller ionic radius and higher hydration energy reduce its compatibility with the hydroxyapatite lattice and favor localization at crystal interfaces rather than deep substitutional sites [263,264]. In consequence, Mg2+ tends to accumulate at crystal boundaries, where it modulates surface energy and growth kinetics and thereby influences enamel solubility and the propensity for post-eruptive acid attack [104,257].
Beyond steady-state distribution, magnesium participates in the transient mineral phases that precede ordered crystal formation. Mg-substituted amorphous calcium phosphate (Mg-ACP) has been detected in early enamel and along crystal boundaries, consistent with a role in stabilizing amorphous precursors, governing the amorphous-to-crystalline transition, and shaping crystallite habit [257,264,265]. The same interfacial chemistry likely underlies Mg-ACP’s reported contributions to fluoride uptake and lesion repair dynamics during early remineralization, linking a trace ion to clinically relevant resilience of the enamel surface [266,267].
These cellular and matrix-level roles position magnesium as both an enzymatic cofactor and a microstructural regulator during maturation. CNNM4-driven efflux prevents pathological Mg2+ accumulation in ameloblasts, while TRPM7-dependent influx supplies the divalent cation needed to optimize ALPL function. At the same time, the intrinsic chemistry of Mg2+ biases it toward crystal surfaces and amorphous intermediates, where it fine-tunes nucleation and growth. When any element of this circuitry is perturbed, such as reduced TRPM7 activity, defective CNNM4 efflux, or altered Mg2+ availability, the consequences cascade from impaired phosphatase activity to disordered mineral assembly, culminating in the characteristic hypomineralized, protein-retentive enamel seen in genetic models and human disease [183,184,227].
Although magnesium is the best defined among the trace elements in enamel, iron provides an instructive counterpoint. In rodents, ameloblasts deposit an iron-rich layer late in maturation, mostly prominent in continuously erupting incisors, that produces the characteristic surface pigmentation [242,268]. This outer iron-rich enamel is measurably more acid-resistant and wear-tolerant than underlying enamel, a conclusion supported by classic etch tests and by recent high-resolution analyses of the iron-enriched surface [269,270,271,272]. Maturation-stage ameloblasts upregulate ferritin heavy chain, reflecting a need for safe intracellular iron sequestration to limit oxidative stress and to support elevated mitochondrial oxidative phosphorylation during the high-demand phases of ion transport and matrix remodeling [1,241,242,270,273,274]. These observations suggest a terminal role for iron in refining surface properties once calcium and phosphate loading is largely complete, and they underscore the broader principle that low-abundance ions can exert outsized influence on enamel’s structure and function.

3.6. Citrate Transport and Its Role in Enamel Mineralization

Beyond divalent cation regulation, citrate handling has emerged as a contributor to enamel mineral chemistry. The Na+-coupled citrate transporter SLC13A5 (NaCT) mediates electrogenic citrate influx (≈ 4 Na+:1 citrate3−) and links epithelial ion transport to intermediary metabolism, positioning citrate to influence HAp growth through transient Ca2+ chelation and surface charge modulation [230]. Genetic loss of Slc13a5 in mice produces failure of enamel maturation with aberrant matrix and markedly reduced mineralized enamel, consistent with an AI-like phenotype, indicating that citrate supply is functionally relevant to amelogenesis [229]. Evidence from metabolic studies further supports a role for NaCT-dependent citrate partitioning in mineralizing tissues, with tooth defects reported when this pathway is perturbed [275].
With respect to cellular localization, recent work localizes NaCT to ameloblast membranes (including basolateral domains and the papillary layer), and sensitive reporter models suggest broad membrane distribution that could support context-dependent citrate flux at the enamel organ interface [231,275]. At the crystal level, citrate adsorbs to apatite surfaces and stabilizes amorphous calcium phosphate (ACP) precursors by chelating Ca2+, delaying premature crystallization until local ionic composition and pH favor HAp formation, mechanistically aligning citrate transport with the RA↔SA cycles that tune matrix chemistry [276,277].

3.7. Phosphate Transport and Regulation During Enamel Maturation

Inorganic phosphate (Pi) is indispensable for the nucleation, elongation, and stabilization of hydroxyapatite in enamel, and its supply increases during maturation as crystals expand in width and thickness [6]. Because crystal growth releases protons into the extracellular space, phosphate flux must be synchronized with calcium delivery and acid-base control. A useful net expression highlighting this proton burden is: 10 Ca2+ + 6 HPO42− + 2 OH → Ca10(PO4)6(OH)2 + 6 H+, that is consistent with the well-established observation that hydroxyapatite precipitation acidifies the enamel fluid and necessitates bicarbonate buffering (Figure 2) [24]. These stoichiometric constraints explain why phosphate handling is tightly coupled to ameloblast modulation, sodium-driven transport, and extracellular pH during maturation, precisely when mineral content and crystallite organization rise most steeply [1,6,87].

3.7.1. Historical Insights into Phosphate Dynamics

During maturation, phosphate delivery to the enamel surface occurs in discrete pulses rather than as a steady flux. Whole-mount radioautography shows that within ~5 min of an intravenous 33P-orthophosphate pulse, label appears as sharply banded uptake confined to the maturation zone and aligned with ruffle-ended/smooth-ended (RA/SA) ameloblast bands [278], an organization independently tracked by polychrome labeling and GBHA staining of sequential SA waves [279]. Compositional contrast by backscattered-electron imaging corroborates the radioautographic band/interband pattern, reinforcing the view that mineral addition is spatially periodic across the zone [280]. Classic tracer work with 32P further indicates that early (pre-maturation) enamel rapidly exchanges phosphate and loses a substantial fraction of label on cold chase, whereas maturation-stage enamel retains most of the label, consistent with durable crystal incorporation at this stage [281]. Chemical profiling across the rat incisor likewise documents stage-dependent shifts in composition that parallel this radiotracer behavior [282]. These pulses coincide with extracellular pH oscillations recorded as alternating acidic and near-neutral bands on developing enamel and with ameloblast-driven cycles of proton secretion and buffering during maturation, providing a mechanistic basis for the coupling of phosphate influx to Ca2+ export and pH control as crystals thicken [6,172].

3.7.2. Phosphate Transporters

Multiple transporter families contribute to phosphate movement across ameloblasts. PiT1/SLC20A1 and PiT2/SLC20A2, and the NaPi-IIb (SLC34A2) mediate cellular uptake, with stage-responsive expression in the enamel organ and known pH sensitivity from their biophysics and epithelial roles (Figure 3) (Table 1).
In mice, NaPi-IIb mRNA is negligible in secretory ameloblasts but rises sharply in maturation, whereas PiT1 is robustly expressed in ameloblasts across secretory and maturation stages, with little signal in odontoblasts, supporting a primary role in ameloblast Pi uptake. PiT2 shows a developmentally dynamic pattern that is a transient, strong signal in young secretory ameloblasts, followed by predominant expression in adjacent enamel-organ support layers (stratum intermedium/papillary; sub-odontoblastic layer) at later stages [1,9,10]. Functionally, both SLC20 carriers prefer H2PO4 over HPO42− ions operating across acidic-alkaline ranges and use a 2 Na+:1 Pi stoichiometry, so their apparent kinetics vary with extracellular pH via phosphate speciation (H2PO4↔HPO42−) rather than a strict pH switch. NaPi-IIb exhibits an optimal activity near mildly acidic pH with regulation by systemic acid-base status (Table 1) [240,283,284]. On the efflux side, the eukaryotic exporter XPR1 is strongly implicated as the apical route for phosphate delivery to the enamel space. Xpr1 is expressed in developing teeth alongside Pi importers, and recent structural work defines XPR1 as the dedicated transmembrane Pi exporter in mammalian cells (Table 1) [9,11]. Their detailed roles, polarity, and regulation will be addressed in the next subsection.
Phosphate delivery is burst-like and synchronized with RA/SA cycling and pH control, supported by intracellular stores and phosphatase activity, and bounded by systemic phosphate availability [6,172,278]. Recent transcriptomic, in situ hybridization, and immunohistochemical studies have clarified the machinery that mediates Pi flux across the enamel organ. Three systems account for most of the major traffic during amelogenesis: type III SLC20 symporters, the type II NaPi-IIb, and the eukaryotic exporter XPR1 [1,5,9,285]. Their expression is stage-specific and epithelial-domain specific within the enamel organ, tracking functional shifts from secretion to maturation and responding to changes in the extracellular milieu, including pH. Bulk and cell-type transcriptomics and in situ hybridization localize Slc34a2 and Slc20a1 to ameloblasts, with Slc34a2 showing a pronounced upregulation in maturation, while Xpr1 is co-expressed at lower levels. This depicts an arrangement consistent with burst delivery of Pi to the mineralization front during RA phases [9,29,80].
(a)
SLC20 family: PiT1 (SLC20A1) and PiT2 (SLC20A2)
PiT1 and PiT2 are type III Na+-phosphate symporters that import the monovalent phosphate species (H2PO4) with an electrogenic 2 Na+:1 Pi stoichiometry, a property established by heterologous transport measurements and refined by recent structural work (Table 1) [237,286]. In vivo mapping across murine tooth germs shows Slc20a1/PiT1 is predominantly expressed in ameloblasts, with signal strongest postnatally and most evident in maturing cells, while odontoblasts are largely negative in these sections. By contrast, multiple dentin/odontoblast model systems and human pulp-derived odontoblasts do express SLC20A1 in vitro, indicating species-, stage-, and model-dependent differences. PiT2 shows a developmentally dynamic pattern that includes a transient but strong signal that appears in secretory ameloblasts, while high and persistent expression is found in the stratum intermedium and, later, the papillary and sub-odontoblastic layers as teeth mature [9,287]. More recent systematic in situ/LacZ analyses similarly localize Slc20a2 away from ameloblasts and into supporting layers [9,287]. Functionally, the SLC20 carriers are widely regarded as “housekeeping” phosphate importers that maintain intracellular Pi for ATP generation and biosynthesis in polarized epithelia. In enamel organs, this role aligns with the energy-intensive transitions from secretion into maturation [288,289]. Older foundational studies that first identified the PiT family as Na+-dependent phosphate symporters using viral receptor clones in oocytes remain key precedents for their transport identity [290].
(b)
SLC34 family: NaPi-IIb (SLC34A2)
NaPi-IIb is the type II sodium-phosphate cotransporter identified in the enamel organ and operates as an electrogenic 3 Na+:1 HPO42− carrier, providing high-capacity Pi transport (Table 1) [237,291]. In rodents, NaPi-IIb expression is low in secretory ameloblasts and rises sharply in maturation, and immunolocalization shows intense signal over the apical plasma membrane of early and late maturation ameloblasts with only weak apical staining in secretory cells. Papillary cells also stain for NaPi-IIb. This stage- and domain-specific pattern aligns with the increased mineral demand and RA↔SA modulation that characterize maturation [1,10]. Beyond stage control, NaPi-IIb function and abundance are pH- and milieu-responsive in epithelia. In the intestine, it exhibits pH-dependent transport kinetics, and its brush-border abundance increases during metabolic acidosis, suggesting a general capacity for acid-linked up-regulation, although this has not yet been demonstrated directly in ameloblasts [292,293,294]. Reports of strong apical NaPi-IIb in late maturation indicate a potential role in the apical Pi uptake from the enamel space into the ameloblasts (Figure 3). Any apical efflux toward the matrix would require a bona fide exporter such as XPR1, but such an apical efflux role remains highly speculative for NaPi-IIb [10].
(c)
XPR1 (phosphate exporter)
XPR1 is the only recognized inorganic phosphate exporter in mammalian cells, and structural and biochemical work now defines its Pi-export mechanism [11,295]. In teeth, XPR1 is expressed during postnatal stages when enamel mineralization accelerates, rising alongside other Pi transporters as ameloblasts shift from matrix secretion toward protein resorption and crystal deposition (Figure 3); this timing is compatible with an efflux role at the matrix-facing surface, although direct membrane-polarity mapping in ameloblasts remains limited. Taken together, the convergence of export mechanism (from other tissues) and developmental expression (in enamel organs) makes XPR1 the leading candidate for the apical efflux limb that complements SLC20/SLC34-mediated uptake (Table 1) [9,11].
Viewed as a system, PiT1, PiT2, NaPi-IIb, and XPR1 form a vectorial, temporally coordinated pathway that couples basolateral Na+-driven Pi uptake to controlled delivery at the distal (matrix-facing) surface (Figure 3). Expression studies in mouse and human tooth germs localize Slc34a2 and Slc20a1 to ameloblasts (with Slc20a2 enriched in supporting layers), and document higher postnatal abundance of XPR1, supporting stage-specific roles across secretion, transition, and maturation. During the secretory stage of enamel formation, Pi entry is dominated by PiT1 and NaPi-IIb, whereas maturation increasingly relies on regulated efflux via XPR1 to fine-tune extracellular Pi, where crystals thicken and widen [9,11]. Stage-dependent changes in transporter abundance and polarity synchronize phosphate supply with Ca2+ export and acid-base control across RA and SA cycles, ensuring precise crystal accretion [29,107]. Finally, pH-responsive regulation of NaPi-IIb is well-documented in epithelia such as the intestine, where acidosis increases NaPi-IIb abundance and transport. This provides a mechanistic precedent for acid-linked up-regulation during the acidic phases of ameloblast modulation, although the direct pH-challenge data in enamel are still emerging [294,296].

3.7.3. Transport Mechanisms and Intracellular Handling of Phosphate During Enamel Maturation

The intracellular fate of phosphate (Pi) in ameloblasts remains incompletely defined, but evidence from enamel and skeletal systems indicates that Pi handling is dynamic, compartmentalized, and enzyme-coupled rather than a simple transcellular conduit. Forming enamel passes through an ACP stage before crystallization, implying regulated precursor control within the epithelium [265,297]. Similarly, mineralizing osteoblasts harbor phosphate- and calcium-rich vesicles contiguous with mitochondria that contribute directly to matrix mineralization [265,298]. After entry, Pi is likely sequestered, chemically modified, and released in a temporally controlled manner, consistent with mammalian evidence for polyphosphate (polyP) pools in mitochondria and in acidic, acidocalcisome-like vesicles [299,300,301].
In a working model extrapolated from mineralizing cells, a portion of imported Pi is condensed into polyP, linear chains of orthophosphate linked by high-energy phosphoanhydride bonds, within mitochondria or acidocalcisome-like compartments [299,302]. PolyP possesses properties well-suited to regulate calcium-phosphate systems. It chelates Ca2+ and interferes with apatite nucleation in a chain-length- and concentration-dependent fashion as it is hydrolytically labile under acidic conditions, and it can associate with and stabilize ACP-like precursors [303]. In ameloblasts, these properties could provide dual functionality. Buffering intracellular phosphate as a mobilizable reserve while stabilizing precursor phases to prevent premature hydroxyapatite formation until ionic composition and pH become favorable. This concept aligns with ACP-to-apatite transitions in enamel and demonstrates that polyP-stabilized ACP converts to apatite under mineralizing conditions [265,304].
At the physicochemical interface, polyP adsorption to nascent mineral surfaces slows phase-transformation kinetics and delays premature crystallization, effects shown historically on hydroxyapatite particles and surfaces [305,306]. Such tunability maps onto enamel’s RA/SA cycling, wherein the extracellular milieu oscillates between mildly acidic and near-neutral states during maturation.
Enzymatic processing at the enamel surface provides the complementary switch from inhibition to supply. ALPL is strongly expressed in the enamel organ and becomes enriched at the distal (apical) pole of transition- and maturation-stage ameloblasts, positioning catalytic activity at the mineralization front [50,307]. In this location, ALPL can hydrolyze polyP to orthophosphate and degrade pyrophosphate (PPi), a potent inhibitor of hydroxyapatite formation [308,309,310]. Because ALPL activity depends on local pH and divalent cofactors such as Mg2+ and Zn2+, apical confinement affords spatial control over extracellular Pi generation and helps avoid cytosolic Pi overload or nonspecific precipitation [311]. This arrangement parallels TNAP’s established role at skeletal mineralization fronts, where matrix-vesicle-rich microenvironments require local PPi hydrolysis and Pi provision to initiate and propagate mineral [312,313]. Notably, alkaline phosphatase isoforms differ in polyP substrate preference: intestinal alkaline phosphatase acts as a highly active exopolyphosphatase across a broad range of chain lengths, whereas ALPL shows limited or context-dependent activity toward longer polyP and reduced activity when polyP is adsorbed to apatite [308,309,314]. These biochemical constraints likely shape how efficiently polyP stores are converted to Pi at the crystal interface.
A vesicular route that couples polyP storage to apical hydrolysis is plausible in ameloblasts, even though no dedicated vesicular Pi transporter has been identified. Current expression maps list plasma-membrane Pi importers (SLC20A1/2; SLC34A2) and the exporter XPR1, leaving the intravesicular conduit undefined [9]. Nonetheless, mammalian cells contain mitochondrial polyP and polyP-containing, acidocalcisome-like vesicles, and mineralizing tissues deploy matrix-vesicle pathways that initiate mineral seeding; osteoblast-derived vesicles concentrate polyP, Ca2+, and phosphatases to nucleate mineral within lipid-bounded microenvironments [312,315,316,317,318,319]. By extension, ameloblasts may route polyP-bearing cargo to the distal membrane, releasing polymer that is then hydrolyzed by apical ALPL to generate short, burst-like increases in Pi coincident with ruffle-ended phases, when mineral growth and acid production peak [1,302,315,320]. Dysregulation of polyP turnover, impaired enzymatic degradation, or defects in vesicular trafficking/transporter coupling would therefore be expected to yield hypomineralization phenotypes, as seen when polyP pathways are perturbed in other mineralizing systems [302,314,321].
Membrane transporters set the intracellular availability and polarity of Pi movement that feed this vesicular-enzymatic axis. Basolateral uptake via Na+/Pi cotransporters of the SLC20 and SLC34 families likely establishes the cellular Pi pool in a stage-dependent manner [9]. A key nuance is the polarity of NaPi-IIb. Although canonically an importer, NaPi-IIb shows strong apical localization in late-maturation ameloblasts [10].
Given well-documented pH-linked regulation of NaPi-IIb in intestinal epithelium, enamel-specific ionic conditions, and potential coupling to vesicular cycling, apical NaPi-IIb could still contribute to distal Pi handling without invoking true efflux [294]. Any bona fide inorganic phosphate efflux across the plasma membrane would most plausibly require XPR1, the only recognized mammalian Pi exporter, whose mechanism has now been defined structurally, and XPR1 is co-expressed with SLC20/34 transporters during postnatal enamel development, consistent with roles at stages when mineral deposition accelerates [9,11]. Thus, while unproven in ameloblasts, the combination of apical NaPi-IIb expression (as an apical importer in maturation) and pH-sensitive regulation keeps it among the candidates that could act alongside XPR1 and apical enzymatic pathways at the matrix-facing pole [10,294].
Taken together, current data support a cohesive, testable model in which basolateral SLC20/SLC34-mediated uptake establishes intracellular phosphate availability; polyP synthesis and vesicular trafficking provide temporal buffering and spatial targeting of phosphate cargo; and apically enriched ALPL converts stored polyP and PPi into orthophosphate precisely at the mineralization front, thereby both supplying substrate and removing inhibition [9,302,307,310]. Priority experiments include identifying polyP-handling enzymes in ameloblasts, verifying the presence and routing of polyP-rich vesicles, and determining whether ALPL functionally interfaces with Na+/Pi transporters and XPR1 to coordinate mineral accretion and pH cycles at maturation [312,315,316].

3.7.4. Systemic Versus Local Regulation of Phosphate Availability (With Temporal Dynamics of Incorporation)

Although enamel mineralization occurs within the enamel organ, it is ultimately constrained by whole-body phosphate (Pi) balance. The kidney reclaims most filtered Pi, and the intestine supplies dietary Pi; therefore, circulating Pi sets the ceiling for enamel use. In mammals, the dominant renal apical transporters are type II Na+/Pi cotransporters NaPi-IIa (SLC34A1) and NaPi-IIc (SLC34A3) in proximal tubule brush border, and loss-of-function in either gene causes renal Pi wasting and hypophosphatemic disease in humans (e.g., SLC34A3-related HHRH; SLC34A1-related proximal tubular Pi-leak phenotypes) [322,323,324]. By contrast, these renal isoforms are essentially absent from developing teeth. In mouse and human tooth germs, SLC34A1 and SLC34A3 are very low/undetectable, whereas SLC34A2 (NaPi-IIb), SLC20A1/2 (PiT1/2), and the exporter XPR1 show robust enamel-organ expression, especially postnatally [9].
Locally, enamel-organ transporters meter delivery at the mineralization front. As detailed above, NaPi-IIb is polarized to the distal domain in maturation-stage ameloblasts; here we note the quantitative shift that accompanies this polarity. NaPi-IIb transcripts rise dramatically across the secretory to maturation switch (≈64-fold in rodent ameloblastomics) [10,29]. Ameloblast modulation imposes alternating acidic and near-neutral matrix bands that Pi delivery must track; classic indicator-dye work recorded ~pH 5.8–6.0 versus ~7.0–7.2 stripes during maturation [6,172]. While direct pH-dependent control of SLC34A2 in ameloblasts remains unproven, epithelial precedents show NaPi-IIb protein can be upregulated several-fold by metabolic acidosis in vivo, consistent with enamel’s acid-base oscillations [294]. In this systemic-local framework, the kidney + intestine set substrate availability; the enamel-organ transporters determine where or when that substrate is immobilized.
The dependence on systemic Pi becomes clinically evident when whole-body homeostasis is perturbed. Inherited or acquired hypophosphatemia, most prominently X-linked hypophosphatemia (XLH) and renal tubular disorders such as Fanconi syndrome, limits Pi delivery to mineralizing tissues and yields hypoplastic or hypomineralized enamel [325,326,327]. Mouse models disrupting renal Na+/Pi cotransporters (NaPi-IIa or NaPi-IIb) exhibit systemic Pi wasting and skeletal mineralization defects, providing a mechanistic bridge to enamel pathology under hypophosphatemic conditions, although enamel phenotypes per se are less completely characterized in these specific knockouts [328]. Notably, the absence of SLC34A1/3 from ameloblasts implies that enamel defects in hypophosphatemic states arise secondarily from reduced circulating Pi rather than loss of a local enamel isoform [9]. Because enamel is acellular and non-remodeling after eruption, any mismatch between circulating Pi and ameloblast transporter capacity during development leaves irreversible defects [1,86].
Temporal radiotracer analyses refine this model by pinpointing when and where Pi is incorporated. Pulse-chase 32P studies reveal a biphasic, developmentally regulated process that demonstrates an early, labile secretory-stage phase marked by rapid uptake into superficial regions that is highly exchangeable (on cold-Pi chase, ~40% label loss, indicating transient binding and high matrix water accessibility), and a prolonged maturation phase in which Pi becomes stably incorporated into hydroxyapatite. The maturation zone retains most label (~10% loss), consistent with lattice entrapment as crystals thicken and porosity declines [6]. In vivo 33P radioautography shows sharply banded incorporation confined to the maturation zone that aligns with RA/SA modulation, underscoring pulsatile, spatially restricted Pi delivery rather than steady accretion [270]. In vitro complements agree: initial labeling concentrates just proximal to the “opaque” boundary marking the onset of maturation, then broadens and homogenizes as diffusion equilibrates and surface area declines with progressive mineralization [274,327]. Shortly after 33P administration (~10 min-4 h), two specific-activity peaks emerge, one in early forming enamel and another at the maturation onset, and over time the dominant peak shifts distally with the eruption trajectory of rat mandibular incisors (≈0.6 mm/day under impeded conditions), confirming that phosphate incorporation couples to tissue movement and ameloblast progression [4,6,329,330]. Concordant pH-indicator stripes (acidic ~5.8–6.0 vs. near-neutral ~7.0–7.2) tie these phosphate pulses to coordinated bicarbonate secretion and matrix processing during the transition from amorphous precursors to organized hydroxyapatite [172,278].
Together, these observations support a temporospatial scheme in which systemic mechanisms maintain circulating Pi required for enamel formation, while local, pH-sensitive transporter programs and ameloblast modulation determine when and where that phosphate is immobilized in the lattice during maturation. This dual-layered regulation confers robustness but also defines vulnerabilities such as dietary insufficiency, genetic disruption of systemic Pi handling, or perturbation of local transporter regulation that can derail delivery during critical windows and leave permanent defects in non-remodeling enamel [6,24].

4. Conclusions and Future Perspectives

Enamel formation is a temporally ordered integration of matrix turnover, epithelial ion transport, and extracellular acid–base control, and maturation succeeds only when these programs advance in phase. The evidence surveyed here across developmental staging, transport physiology, and clinical genetics supports a view in which tissue durability arises from the synchronization of cellular modulation with interfacial chemistry.
Within this integrated picture, phosphate transport is a principal organizing axis of maturation. Classical observations of radiotracer banding and surface pH oscillations indicate episodic and spatially delimited phosphate delivery that aligns with ameloblast modulation. Crystal thickening proceeds efficiently only when phosphate availability, interfacial pH, and matrix proteolysis are co-timed, and perturbations that alter the amplitude or timing of any one of these processes predictably impair mineral accretion and leave enamel enriched in protein and water.
A concise mechanistic framework follows. Basolateral uptake of phosphate, intracellular buffering that separates uptake from release in time, controlled apical export into the forming tissue, and enzymatic hydrolysis at the mineralization front that removes inhibitors such as pyrophosphate collectively sustain orthophosphate activity at the crystal surface. This flux is functionally coupled to bicarbonate-based proton handling and to calcium delivery, so the effective balance among Ca, Pi, and pH at the interface is set by epithelial transport rather than by bulk fluids. The specific molecular details are developed in the main text, and the key point here is that coordination among modules rather than the maximal capacity of any single module governs maturation outcomes.
Resolving the remaining uncertainties requires quantitative experiments in situ. Transporter topology and dynamics must be mapped across ruffle-ended and smooth-ended phases. Phosphate buffering and release at the ameloblast interface need molecular specificity. The phase relationships among phosphate delivery, acid–base compensation, calcium flux, and proteolysis should be measured within the same preparation. Spatially registered molecular atlases along the incisor growth axis, live reporters for key ions integrated with ultrastructural readouts, and targeted inducible perturbations provide a tractable path to causal resolution and to parameterized models that predict crystal thickening and tissue mechanics.
Clinical translation should treat phosphate delivery as a controllable variable. Systemic correction of hypophosphatemia should be evaluated with enamel-specific endpoints that report crystal thickness, residual matrix and water, and fracture behavior, but not hardness alone. Local and time-restricted enhancement of phosphate availability or interfacial enzymatic activity during maturation merits testing, provided that acid–base and calcium modules are co-optimized to avoid ectopic or heterogeneous precipitation. Biomimetic repair strategies that tune the interfacial balance among Ca, Pi, and pH and that leverage condensed phosphate chemistries may standardize the quality of enamel-like mineral produced ex vivo and inform minimally invasive interventions. Incorporating genotypes that affect phosphate handling into care pathways can improve risk stratification and the timing of definitive restorations.
Taken together, the synthesis advanced here reframes amelogenesis as a phosphate-paced physiology that coordinates epithelial transport with matrix physics to produce a durable and near anhydrous ceramic. Centering phosphate as the integrator moves the field from descriptive staging toward predictive and testable models and toward mechanism-guided strategies for prevention, diagnosis, and repair.

Funding

This work was funded by NIH/NIDCR grants UG3/UH3DE028850, R01DE029445, and R01DE034447 (M.L.P.), and R90DE022528 (M.L.P., R.A.B.).

Acknowledgments

We thank Janice Bea for help with reviewing and editing the manuscript. The authors used ChatGPT5 (OpenAI, San Francisco, CA, USA) for language editing assistance. All scientific content and conclusions are the authors’ own. Figures created using https://BioRender.com.

Conflicts of Interest

The authors declare no financial or non-financial competing interests.

References

  1. Lacruz, R.S.; Habelitz, S.; Wright, J.T.; Paine, M.L. Dental Enamel Formation and Implications for Oral Health and Disease. Physiol. Rev. 2017, 97, 939–993. [Google Scholar] [CrossRef] [PubMed]
  2. Jayasudha; Baswaraj; HK, N.; KB, P. Enamel regeneration—Current progress and challenges. J. Clin. Diagn. Res. 2014, 8, ZE06–ZE09. [Google Scholar]
  3. Bartlett, J.D. Dental enamel development: Proteinases and their enamel matrix substrates. ISRN Dent. 2013, 2013, 684607. [Google Scholar] [CrossRef]
  4. Smith, C.E. Cellular and chemical events during enamel maturation. Crit. Rev. Oral Biol. Med. 1998, 9, 128–161. [Google Scholar] [CrossRef]
  5. Lacruz, R.S. Enamel: Molecular identity of its transepithelial ion transport system. Cell Calcium 2017, 65, 1–7. [Google Scholar] [CrossRef]
  6. Robinson, C. Enamel maturation: A brief background with implications for some enamel dysplasias. Front. Physiol. 2014, 5, 388. [Google Scholar] [CrossRef]
  7. Bronckers, A.L. Ion Transport by Ameloblasts during Amelogenesis. J. Dent. Res. 2017, 96, 243–253. [Google Scholar]
  8. Wong, F.S.; Elliott, J.C.; Davis, G.R.; Anderson, P. X-ray microtomographic study of mineral distribution in enamel of mandibular rat incisors. J. Anat. 2000, 196 Pt 3, 405–413. [Google Scholar] [CrossRef] [PubMed]
  9. Merametdjian, L.; David, A.; Bon, N.; Couasnay, G.; Guicheux, J.; Gaucher, C.; Beck-Cormier, S.; Beck, L. Expression of Phosphate Transporters during Dental Mineralization. J. Dent. Res. 2018, 97, 209–217. [Google Scholar] [PubMed]
  10. Bronckers, A.L.; Lyaruu, D.; Jalali, R.; Medina, J.F.; Zandieh-Doulabi, B.; DenBesten, P.K. Ameloblast Modulation and Transport of Cl, Na+, and K+ during Amelogenesis. J. Dent. Res. 2015, 94, 1740–1747. [Google Scholar] [CrossRef]
  11. Yan, R.; Chen, H.; Liu, C.; Zhao, J.; Wu, D.; Jiang, J.; Gong, J.; Jiang, D. Human XPR1 structures reveal phosphate export mechanism. Nature 2024, 633, 960–967. [Google Scholar] [CrossRef] [PubMed]
  12. Larsson, A.; Regnstrand, T.; Skott, P.; Mäkitie, O.; Björnsdottir, S.; Garming-Legert, K. Dental health of patients with X-linked hypophosphatemia: A controlled study. Front. Oral Health 2023, 4, 1087761. [Google Scholar] [CrossRef]
  13. Nanci, A.; Ten Cate, A.R. Ten Cate’s Oral Histology: Development, Structure, and Function, 8th ed.; Elsevier: St. Louis, MO, USA, 2013; p. 407. [Google Scholar]
  14. Klein, O.D.; Duverger, O.; Shaw, W.; Lacruz, R.S.; Joester, D.; Moradian-Oldak, J.; Pugach, M.K.; Wright, J.T.; Millar, S.E.; Kulkarni, A.B.; et al. Meeting report: A hard look at the state of enamel research. Int. J. Oral Sci. 2017, 9, e3. [Google Scholar] [CrossRef]
  15. Kegulian, N.C.; Visakan, G.; Bapat, R.A.; Moradian-Oldak, J. Ameloblastin and its multifunctionality in amelogenesis: A review. Matrix Biol. 2024, 131, 62–76. [Google Scholar] [CrossRef] [PubMed]
  16. Baranova, J.; Büchner, D.; Götz, W.; Schulze, M.; Tobiasch, E. Tooth Formation: Are the Hardest Tissues of Human Body Hard to Regenerate? Int. J. Mol. Sci. 2020, 21, 4031. [Google Scholar] [CrossRef]
  17. Balic, A. Concise Review: Cellular and Molecular Mechanisms Regulation of Tooth Initiation. Stem Cells 2019, 37, 26–32. [Google Scholar] [CrossRef] [PubMed]
  18. Morita, K.; Wang, J.; Okamoto, K.; Iwata, T. The next generation of regenerative dentistry: From tooth development biology to periodontal tissue, dental pulp, and whole tooth reconstruction in the clinical setting. Regen. Ther. 2025, 28, 333–344. [Google Scholar] [CrossRef]
  19. Biggs, L.C.; Mikkola, M.L. Early inductive events in ectodermal appendage morphogenesis. Semin. Cell Dev. Biol. 2014, 25–26, 11–21. [Google Scholar] [CrossRef]
  20. Jussila, M.; Thesleff, I. Signaling networks regulating tooth organogenesis and regeneration, and the specification of dental mesenchymal and epithelial cell lineages. Cold Spring Harb. Perspect. Biol. 2012, 4, a008425. [Google Scholar] [CrossRef]
  21. Novacescu, D.; Dumitru, C.S.; Zara, F.; Raica, M.; Suciu, C.S.; Barb, A.C.; Rakitovan, M.; Armega Anghelescu, A.; Cindrea, A.C.; Diana, S.; et al. The Morphogenesis, Pathogenesis, and Molecular Regulation of Human Tooth Development—A Histological Review. Int. J. Mol. Sci. 2025, 26, 6209. [Google Scholar] [CrossRef]
  22. Robinson, C.; Brookes, S.J.; Shore, R.C.; Kirkham, J. The developing enamel matrix: Nature and function. Eur. J. Oral Sci. 1998, 106 (Suppl. S1), 282–291. [Google Scholar] [CrossRef]
  23. Warshawsky, H. The fine structure of secretory ameloblasts in rat incisors. Anat. Rec. 1968, 161, 211–229. [Google Scholar] [CrossRef]
  24. Lacruz, R.S.; Nanci, A.; Kurtz, I.; Wright, J.T.; Paine, M.L. Regulation of pH During Amelogenesis. Calcif. Tissue Int. 2010, 86, 91–103. [Google Scholar] [CrossRef]
  25. Smith, C.E.L.; Poulter, J.A.; Antanaviciute, A.; Kirkham, J.; Brookes, S.J.; Inglehearn, C.F.; Mighell, A.J. Amelogenesis Imperfecta; Genes, Proteins, and Pathways. Front. Physiol. 2017, 8, 435. [Google Scholar] [CrossRef]
  26. Warshawsky, H.; Smith, C.E. Morphological classification of rat incisor ameloblasts. Anat. Rec. 1974, 179, 423–446. [Google Scholar] [CrossRef] [PubMed]
  27. Reith, E.J. The stages of amelogenesis as observed in molar teeth of young rats. J. Ultrastruct. Res. 1970, 30, 111–151. [Google Scholar] [CrossRef]
  28. Smith, C.E.; Nanci, A. Protein dynamics of amelogenesis. Anat. Rec. 1996, 245, 186–207. [Google Scholar] [CrossRef]
  29. Lacruz, R.S.; Smith, C.E.; Kurtz, I.; Hubbard, M.J.; Paine, M.L. New paradigms on the transport functions of maturation-stage ameloblasts. J. Dent. Res. 2013, 92, 122–129. [Google Scholar] [CrossRef] [PubMed]
  30. Nanci, A. Ten Cate’s Oral Histology: Development, Structure, and Function, 9th ed.; Elsevier: St. Louis, MO, USA, 2023. [Google Scholar]
  31. Thesleff, I.; Hurmerinta, K. Tissue interactions in tooth development. Differentiation 1981, 18, 75–88. [Google Scholar] [CrossRef]
  32. Reibring, C.G.; El Shahawy, M.; Hallberg, K.; Harfe, B.D.; Linde, A.; Gritli-Linde, A. Loss of BMP2 and BMP4 Signaling in the Dental Epithelium Causes Defective Enamel Maturation and Aberrant Development of Ameloblasts. Int. J. Mol. Sci. 2022, 23, 6095. [Google Scholar] [CrossRef] [PubMed]
  33. Bei, M. Molecular genetics of ameloblast cell lineage. J. Exp. Zool. B Mol. Dev. Evol. 2009, 312B, 437–444. [Google Scholar] [CrossRef]
  34. He, P.; Zhang, Y.; Kim, S.O.; Radlanski, R.J.; Butcher, K.; Schneider, R.A.; DenBesten, P.K. Ameloblast differentiation in the human developing tooth: Effects of extracellular matrices. Matrix Biol. 2010, 29, 411–419. [Google Scholar] [CrossRef] [PubMed]
  35. Karcher-Djuricic, V.; Staubli, A.; Meyer, J.M.; Ruch, J.V. Acellular dental matrices promote functional differentiation of ameloblasts. Differentiation 1985, 29, 169–175. [Google Scholar] [CrossRef]
  36. Pham, C.D.; Smith, C.E.; Hu, Y.; Hu, J.C.; Simmer, J.P.; Chun, Y.P. Endocytosis and Enamel Formation. Front. Physiol. 2017, 8, 529. [Google Scholar] [CrossRef]
  37. Begue-Kirn, C.; Krebsbach, P.H.; Bartlett, J.D.; Butler, W.T. Dentin sialoprotein, dentin phosphoprotein, enamelysin and ameloblastin: Tooth-specific molecules that are distinctively expressed during murine dental differentiation. Eur. J. Oral Sci. 1998, 106, 963–970. [Google Scholar] [CrossRef]
  38. Visakan, G.; Su, J.; Moradian-Oldak, J. Ameloblastin promotes polarization of ameloblast cell lines in a 3-D cell culture system. Matrix Biol. 2022, 105, 72–86. [Google Scholar] [CrossRef] [PubMed]
  39. Reith, E.J. The ultrastructure of ameloblasts during matrix formation and the maturation of enamel. J. Biophys. Biochem. Cytol. 1961, 9, 825–839. [Google Scholar] [CrossRef]
  40. Yoshizaki, K.; Fukumoto, S.; Bikle, D.D.; Oda, Y. Transcriptional Regulation of Dental Epithelial Cell Fate. Int. J. Mol. Sci. 2020, 21, 8952. [Google Scholar] [CrossRef]
  41. Hu, J.C.; Hu, Y.; Smith, C.E.; McKee, M.D.; Wright, J.T.; Yamakoshi, Y.; Papagerakis, P.; Hunter, G.K.; Feng, J.Q.; Yamakoshi, F.; et al. Enamel defects and ameloblast-specific expression in Enam knock-out/lacz knock-in mice. J. Biol. Chem. 2008, 283, 10858–10871. [Google Scholar] [CrossRef]
  42. Nanci, A.; Zalzal, S.; Lavoie, P.; Kunikata, M.; Chen, W.; Krebsbach, P.H.; Yamada, Y.; Hammarström, L.; Simmer, J.P.; Fincham, A.G.; et al. Comparative immunochemical analyses of the developmental expression and distribution of ameloblastin and amelogenin in rat incisors. J. Histochem. Cytochem. 1998, 46, 911–934. [Google Scholar] [CrossRef] [PubMed]
  43. Landin, M.A.; Shabestari, M.; Babaie, E.; Reseland, J.E.; Osmundsen, H. Gene Expression Profiling during Murine Tooth Development. Front. Genet. 2012, 3, 139. [Google Scholar] [CrossRef]
  44. Vainio, S.; Karavanova, I.; Jowett, A.; Thesleff, I. Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during early tooth development. Cell 1993, 75, 45–58. [Google Scholar] [CrossRef] [PubMed]
  45. Kettunen, P.; Laurikkala, J.; Itäranta, P.; Vainio, S.; Itoh, N.; Thesleff, I. Associations of FGF-3 and FGF-10 with signaling networks regulating tooth morphogenesis. Dev. Dyn. 2000, 219, 322–332. [Google Scholar] [CrossRef]
  46. Dassule, H.R.; Lewis, P.; Bei, M.; Maas, R.; McMahon, A.P. Sonic hedgehog regulates growth and morphogenesis of the tooth. Development 2000, 127, 4775–4785. [Google Scholar] [CrossRef]
  47. Krebsbach, P.H.; Lee, S.K.; Matsuki, Y.; Kozak, C.A.; Yamada, K.M.; Yamada, Y. Full-length sequence, localization, and chromosomal mapping of ameloblastin. A novel tooth-specific gene. J. Biol. Chem. 1996, 271, 4431–4435. [Google Scholar] [CrossRef]
  48. Fukumoto, S.; Kiba, T.; Hall, B.; Iehara, N.; Nakamura, T.; Longenecker, G.; Krebsbach, P.H.; Nanci, A.; Kulkarni, A.B.; Yamada, Y. Ameloblastin is a cell adhesion molecule required for maintaining the differentiation state of ameloblasts. J. Cell Biol. 2004, 167, 973–983. [Google Scholar] [CrossRef]
  49. Paine, M.L.; White, S.N.; Luo, W.; Fong, H.; Sarikaya, M.; Snead, M.L. Regulated gene expression dictates enamel structure and tooth function. Matrix Biol. 2001, 20, 273–292. [Google Scholar] [CrossRef]
  50. Deporter, D.A.; Ten Cate, A.R. Fine structural localization of alkaline phosphatase in relation to enamel formation in the mouse molar. Arch. Oral Biol. 1976, 21, 7–12. [Google Scholar] [CrossRef]
  51. Ten Cate, A.R. The distribution of alkaline phosphatase in the human tooth germ. Arch. Oral Biol. 1962, 7, 195–205. [Google Scholar] [CrossRef] [PubMed]
  52. Ida-Yonemochi, H.; Ohshiro, K.; Swelam, W.; Metwaly, H.; Saku, T. Perlecan, a basement membrane-type heparan sulfate proteoglycan, in the enamel organ: Its intraepithelial localization in the stellate reticulum. J. Histochem. Cytochem. 2005, 53, 763–772. [Google Scholar] [CrossRef] [PubMed]
  53. Katchburian, E.; Holt, S.J. Studies on the development of ameloblasts. I. Fine structure. J. Cell Sci. 1972, 11, 415–447. [Google Scholar] [CrossRef]
  54. Simmer, J.P.; Richardson, A.S.; Hu, Y.Y.; Smith, C.E.; Ching-Chun Hu, J. A post-classical theory of enamel biomineralization... and why we need one. Int. J. Oral Sci. 2012, 4, 129–134. [Google Scholar] [CrossRef] [PubMed]
  55. Bartlett, J.D.; Simmer, J.P. Kallikrein-related peptidase-4 (KLK4): Role in enamel formation and revelations from ablated mice. Front. Physiol. 2014, 5, 240. [Google Scholar] [CrossRef] [PubMed]
  56. Leblond, C.P.; Warshawsky, H. Dynamics of enamel formation in the rat incisor tooth. J. Dent. Res. 1979, 58, 950–975. [Google Scholar] [CrossRef] [PubMed]
  57. Fukae, M.; Tanabe, T.; Murakami, C.; Dohi, N.; Uchida, T.; Shimizu, M. Primary structure of the porcine 89-kDa enamelin. Adv. Dent. Res. 1996, 10, 111–118. [Google Scholar] [CrossRef] [PubMed]
  58. Fang, P.A.; Conway, J.F.; Margolis, H.C.; Simmer, J.P.; Beniash, E. Hierarchical self-assembly of amelogenin and the regulation of biomineralization at the nanoscale. Proc. Natl. Acad. Sci. USA 2011, 108, 14097–14102. [Google Scholar] [CrossRef]
  59. Fincham, A.G.; Moradian-Oldak, J.; Diekwisch, T.G.; Lyaruu, D.M.; Wright, J.T.; Bringas, P., Jr.; Slavkin, H.C. Evidence for amelogenin “nanospheres” as functional components of secretory-stage enamel matrix. J. Struct. Biol. 1995, 115, 50–59. [Google Scholar] [CrossRef]
  60. Beniash, E.; Simmer, J.P.; Margolis, H.C. The effect of recombinant mouse amelogenins on the formation and organization of hydroxyapatite crystals in vitro. J. Struct. Biol. 2005, 149, 182–190. [Google Scholar] [CrossRef] [PubMed]
  61. Yamazaki, H.; Tran, B.; Beniash, E.; Kwak, S.Y.; Margolis, H.C. Proteolysis by MMP20 Prevents Aberrant Mineralization in Secretory Enamel. J. Dent. Res. 2019, 98, 468–475. [Google Scholar] [CrossRef]
  62. Zhang, Y.; Jin, T.; Zhu, W.; Pandya, M.; Gopinathan, G.; Allen, M.; Reed, D.; Keiderling, T.; Liao, X.; Diekwisch, T.G.H. Highly acidic pH facilitates enamel protein self-assembly, apatite crystal growth and enamel protein interactions in the early enamel matrix. Front. Physiol. 2022, 13, 1019364. [Google Scholar]
  63. Bartlett, J.D.; Jin, T.; Zhu, W.; Pandya, M.; Gopinathan, G.; Allen, M.; Reed, D.; Keiderling, T.; Liao, X.; Diekwisch, T.G.H. MMP20-generated amelogenin cleavage products prevent formation of fan-shaped enamel malformations. Sci. Rep. 2021, 11, 10570. [Google Scholar] [CrossRef] [PubMed]
  64. Simmer, J.P.; Hu, J.C.; Hu, Y.; Zhang, S.; Liang, T.; Wang, S.K.; Kim, J.W.; Yamakoshi, Y.; Chun, Y.H.; Bartlett, J.D.; et al. A genetic model for the secretory stage of dental enamel formation. J. Struct. Biol. 2021, 213, 107805. [Google Scholar] [CrossRef] [PubMed]
  65. Smith, C.E.; Hu, Y.; Hu, J.C.; Simmer, J.P. Ultrastructure of early amelogenesis in wild-type, Amelx−/−, and Enam−/− mice: Enamel ribbon initiation on dentin mineral and ribbon orientation by ameloblasts. Mol. Genet. Genom. Med. 2016, 4, 662–683. [Google Scholar] [CrossRef]
  66. Stifler, C.A.; Yamazaki, H.; Gilbert, P.U.P.A.; Margolis, H.C.; Beniash, E. Loss of biological control of enamel mineralization in amelogenin-phosphorylation-deficient mice. J. Struct. Biol. 2022, 214, 107844. [Google Scholar] [CrossRef]
  67. Woltgens, J.H.; Lyaruu, D.M.; Bronckers, A.L.; Bervoets, T.J.; Van Duin, M. Biomineralization during early stages of the developing tooth in vitro with special reference to secretory stage of amelogenesis. Int. J. Dev. Biol. 1995, 39, 203–212. [Google Scholar]
  68. Al-Ansari, S.; Jalali, R.; Plotkin, L.I.; Bronckers, A.L.J.J.; DenBesten, P.; Zhang, Y.; Raber-Durlacher, J.E.; de Lange, J.; Rozema, F.R. The Importance of Connexin 43 in Enamel Development and Mineralization. Front. Physiol. 2018, 9, 750. [Google Scholar] [CrossRef] [PubMed]
  69. Antoine, D.; Hillson, S.; Dean, M.C. The developmental clock of dental enamel: A test for the periodicity of prism cross-striations in modern humans and an evaluation of the most likely sources of error in histological studies of this kind. J. Anat. 2009, 214, 45–55. [Google Scholar] [CrossRef] [PubMed]
  70. Dean, M.C.; Humphrey, L.; Groom, A.; Hassett, B. Variation in the timing of enamel formation in modern human deciduous canines. Arch. Oral Biol. 2020, 114, 104719. [Google Scholar] [CrossRef]
  71. McFarlane, G.; Loch, C.; Guatelli-Steinberg, D.; Bayle, P.; Le Luyer, M.; Sabel, N.; Nava, A.; Floyd, B.; Skinner, M.; White, S.; et al. Enamel daily secretion rates of deciduous molars from a global sample of children. Arch. Oral Biol. 2021, 132, 105290. [Google Scholar] [CrossRef]
  72. Reid, D.J.; Ferrell, R.J. The relationship between number of striae of Retzius and their periodicity in imbricational enamel formation. J. Hum. Evol. 2006, 50, 195–202. [Google Scholar] [CrossRef]
  73. Modesto-Mata, M.; Dean, M.C.; Lacruz, R.S.; Bromage, T.G.; García-Campos, C.; Martínez de Pinillos, M.; Martín-Francés, L.; Martinón-Torres, M.; Carbonell, E.; Arsuaga, J.L.; et al. Short and long period growth markers of enamel formation distinguish European Pleistocene hominins. Sci. Rep. 2020, 10, 4665. [Google Scholar] [CrossRef]
  74. Eli, I.; Sarnat, H.; Talmi, E. Effect of the birth process on the neonatal line in primary tooth enamel. Pediatr. Dent. 1989, 11, 220–223. [Google Scholar]
  75. Mountain, R.V.; Zhu, Y.; Pickett, O.R.; Lussier, A.A.; Goldstein, J.M.; Roffman, J.L.; Bidlack, F.B.; Dunn, E.C. Association of Maternal Stress and Social Support During Pregnancy with Growth Marks in Children’s Primary Tooth Enamel. JAMA Netw. Open 2021, 4, e2129129. [Google Scholar] [CrossRef]
  76. Harada, H.; Kettunen, P.; Jung, H.S.; Mustonen, T.; Wang, Y.A.; Thesleff, I. Localization of putative stem cells in dental epithelium and their association with Notch and FGF signaling. J. Cell Biol. 1999, 147, 105–120. [Google Scholar] [CrossRef] [PubMed]
  77. Juuri, E.; Saito, K.; Ahtiainen, L.; Seidel, K.; Tummers, M.; Hochedlinger, K.; Klein, O.D.; Thesleff, I.; Michon, F. Sox2+ stem cells contribute to all epithelial lineages of the tooth via Sfrp5+ progenitors. Dev. Cell 2012, 23, 317–328. [Google Scholar] [CrossRef]
  78. Li, J.; Feng, J.; Liu, Y.; Ho, T.V.; Grimes, W.; Ho, H.A.; Park, S.; Wang, S.; Chai, Y. BMP-SHH signaling network controls epithelial stem cell fate via regulation of its niche in the developing tooth. Dev. Cell 2015, 33, 125–135. [Google Scholar] [CrossRef]
  79. Alghadeer, A.; Hanson-Drury, S.; Patni, A.P.; Ehnes, D.D.; Zhao, Y.T.; Li, Z.; Phal, A.; Vincent, T.; Lim, Y.C.; O’Day, D.; et al. Single-cell census of human tooth development enables generation of human enamel. Dev. Cell 2023, 58, 2163–2180e9. [Google Scholar] [CrossRef] [PubMed]
  80. Simmer, J.P.; Richardson, A.S.; Wang, S.K.; Reid, B.M.; Bai, Y.; Hu, Y.; Hu, J.C. Ameloblast transcriptome changes from secretory to maturation stages. Connect. Tissue Res. 2014, 55, 29–32. [Google Scholar] [CrossRef]
  81. Wang, S.; Choi, M.; Richardson, A.S.; Reid, B.M.; Seymen, F.; Yildirim, M.; Tuna, E.; Gençay, K.; Simmer, J.P.; Hu, J.C. STIM1 and SLC24A4 Are Critical for Enamel Maturation. J. Dent. Res. 2014, 93, 94S–100S. [Google Scholar] [CrossRef]
  82. Smith, C.E.; Issid, M.; Margolis, H.C.; Moreno, E.C. Developmental changes in the pH of enamel fluid and its effects on matrix-resident proteinases. Adv. Dent. Res. 1996, 10, 159–169. [Google Scholar] [CrossRef] [PubMed]
  83. Kallenbach, E. Fine structure of the stratum intermedium, stellate reticulum, and outer enamel epithelium in the enamel organ of the kitten. J. Anat. 1978, 126 Pt 2, 247–260. [Google Scholar]
  84. Kallenbach, E. Fine structure of rat incisor ameloblasts in transition between enamel secretion and maturation stages. Tissue Cell 1974, 6, 173–190. [Google Scholar] [CrossRef]
  85. Costiniti, V.; Bomfim, G.H.; Li, Y.; Mitaishvili, E.; Ye, Z.W.; Zhang, J.; Townsend, D.M.; Giacomello, M.; Lacruz, R.S. Mitochondrial Function in Enamel Development. Front. Physiol. 2020, 11, 538. [Google Scholar] [CrossRef]
  86. Simmer, J.P.; Papagerakis, P.; Smith, C.E.; Fisher, D.C.; Rountrey, A.N.; Zheng, L.; Hu, J.C. Regulation of dental enamel shape and hardness. J. Dent. Res. 2010, 89, 1024–1038. [Google Scholar] [CrossRef]
  87. Jalali, R.; Guo, J.; Zandieh-Doulabi, B.; Bervoets, T.J.; Paine, M.L.; Boron, W.F.; Parker, M.D.; Bijvelds, M.J.; Medina, J.F.; DenBesten, P.K.; et al. NBCe1 (SLC4A4) a potential pH regulator in enamel organ cells during enamel development in the mouse. Cell Tissue Res. 2014, 358, 433–442. [Google Scholar] [CrossRef] [PubMed]
  88. Yin, K.; Paine, M.L. Bicarbonate Transport During Enamel Maturation. Calcif. Tissue Int. 2017, 101, 457–464. [Google Scholar] [CrossRef]
  89. Skobe, Z. The vascular pattern in the papillary region of rat incisor and molar tooth enamel organ. J. Dent. Res. 1980, 59, 1457–1460. [Google Scholar] [CrossRef]
  90. Garant, P.R.; Nagy, A.R.; Cho, M.I. A freeze-fracture study of the papillary layer of the rat incisor enamel organ. Tissue Cell 1984, 16, 635–645. [Google Scholar] [CrossRef]
  91. Smith, C.E.L.; Kirkham, J.; Day, P.F.; Soldani, F.; McDerra, E.J.; Poulter, J.A.; Inglehearn, C.F.; Mighell, A.J.; Brookes, S.J. A Fourth KLK4 Mutation Is Associated with Enamel Hypomineralisation and Structural Abnormalities. Front. Physiol. 2017, 8, 333. [Google Scholar] [CrossRef] [PubMed]
  92. Lyaruu, D.M.; Bronckers, A.L.; Mulder, L.; Mardones, P.; Medina, J.F.; Kellokumpu, S.; Oude Elferink, R.P.; Everts, V. The anion exchanger Ae2 is required for enamel maturation in mouse teeth. Matrix Biol. 2008, 27, 119–127. [Google Scholar] [CrossRef] [PubMed]
  93. Bronckers, A.; Kalogeraki, L.; Jorna, H.J.; Wilke, M.; Bervoets, T.J.; Lyaruu, D.M.; Zandieh-Doulabi, B.; Denbesten, P.; de Jonge, H. The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells. Bone 2010, 46, 1188–1196. [Google Scholar] [CrossRef]
  94. Lin, H.M.; Nakamura, H.; Noda, T.; Ozawa, H. Localization of H+-ATPase and carbonic anhydrase II in ameloblasts at maturation. Calcif. Tissue Int. 1994, 55, 38–45. [Google Scholar] [CrossRef]
  95. Krajewski, S.; Hugger, A.; Krajewska, M.; Reed, J.C.; Mai, J.K. Developmental expression patterns of Bcl-2, Bcl-x, Bax, and Bak in teeth. Cell Death Differ. 1998, 5, 408–415. [Google Scholar] [CrossRef]
  96. Kubota, K.; Lee, D.H.; Tsuchiya, M.; Young, C.S.; Everett, E.T.; Martinez-Mier, E.A.; Snead, M.L.; Nguyen, L.; Urano, F.; Bartlett, J.D. Fluoride induces endoplasmic reticulum stress in ameloblasts responsible for dental enamel formation. J. Biol. Chem. 2005, 280, 23194–23202. [Google Scholar] [CrossRef]
  97. Zhang, Y.; Zhang, K.; Ma, L.; Gu, H.; Li, J.; Lei, S. Fluoride induced endoplasmic reticulum stress and calcium overload in ameloblasts. Arch. Oral Biol. 2016, 69, 95–101. [Google Scholar] [CrossRef]
  98. Tsuchiya, M.; Sharma, R.; Tye, C.E.; Sugiyama, T.; Bartlett, J.D. Transforming growth factor-beta1 expression is up-regulated in maturation-stage enamel organ and may induce ameloblast apoptosis. Eur. J. Oral Sci. 2009, 117, 105–112. [Google Scholar] [CrossRef] [PubMed]
  99. Ma, X.; Ma, Y.; Lin, Z.; Ji, M. The role of the TGF-beta1 signaling pathway in the process of amelogenesis. Front. Physiol. 2025, 16, 1586769. [Google Scholar] [CrossRef] [PubMed]
  100. Abramyan, J.; Geetha-Loganathan, P.; Šulcová, M.; Buchtová, M. Role of Cell Death in Cellular Processes During Odontogenesis. Front. Cell Dev. Biol. 2021, 9, 671475. [Google Scholar] [CrossRef] [PubMed]
  101. Eckstein, M.; Vaeth, M.; Fornai, C.; Vinu, M.; Bromage, T.G.; Nurbaeva, M.K.; Sorge, J.L.; Coelho, P.G.; Idaghdour, Y.; Feske, S.; et al. Store-operated Ca2+ entry controls ameloblast cell function and enamel development. JCI Insight 2017, 2, e91166. [Google Scholar] [CrossRef] [PubMed]
  102. Liang, T.; Hu, Y.; Kawasaki, K.; Zhang, H.; Zhang, C.; Saunders, T.L.; Simmer, J.P.; Hu, J.C. Odontogenesis-associated phosphoprotein truncation blocks ameloblast transition into maturation in OdaphC41*/C41* mice. Sci. Rep. 2021, 11, 1132. [Google Scholar] [CrossRef]
  103. Beniash, E.; Stifler, C.A.; Sun, C.Y.; Jung, G.S.; Qin, Z.; Buehler, M.J.; Gilbert, P.U.P.A. The hidden structure of human enamel. Nat. Commun. 2019, 10, 4383. [Google Scholar] [CrossRef]
  104. Free, R.; DeRocher, K.; Cooley, V.; Xu, R.; Stock, S.R.; Joester, D. Mesoscale structural gradients in human tooth enamel. Proc. Natl. Acad. Sci. USA 2022, 119, e2211285119. [Google Scholar] [CrossRef] [PubMed]
  105. Robinson, C.; Kirkham, J.; Hallsworth, A.S. Volume distribution and concentration of protein, mineral and water in developing bovine enamel. Arch. Oral Biol. 1988, 33, 159–162. [Google Scholar] [CrossRef]
  106. Weatherell, J.A.; Robinson, C.; Hallsworth, A.S. Variations in the chemical composition of human enamel. J. Dent. Res. 1974, 53, 180–192. [Google Scholar] [CrossRef] [PubMed]
  107. Damkier, H.H.; Josephsen, K.; Takano, Y.; Zahn, D.; Fejerskov, O.; Frische, S. Fluctuations in surface pH of maturing rat incisor enamel are a result of cycles of H+-secretion by ameloblasts and variations in enamel buffer characteristics. Bone 2014, 60, 227–234. [Google Scholar] [CrossRef]
  108. Simmer, J.P.; Hu, Y.; Lertlam, R.; Yamakoshi, Y.; Hu, J.C. Hypomaturation enamel defects in Klk4 knockout/LacZ knockin mice. J. Biol. Chem. 2009, 284, 19110–19121. [Google Scholar] [CrossRef] [PubMed]
  109. Smith, C.E.; Richardson, A.S.; Hu, Y.; Bartlett, J.D.; Hu, J.C.; Simmer, J.P. Effect of kallikrein 4 loss on enamel mineralization: Comparison with mice lacking matrix metalloproteinase 20. J. Biol. Chem. 2011, 286, 18149–18160. [Google Scholar] [CrossRef] [PubMed]
  110. Robinson, C.; Connell, S.; Brookes, S.J.; Kirkham, J.; Shore, R.C.; Smith, D.A. Surface chemistry of enamel apatite during maturation in relation to pH: Implications for protein removal and crystal growth. Arch. Oral Biol. 2005, 50, 267–270. [Google Scholar] [CrossRef]
  111. Liu, H.; Yan, X.; Pandya, M.; Luan, X.; Diekwisch, T.G. Daughters of the Enamel Organ: Development, Fate, and Function of the Stratum Intermedium, Stellate Reticulum, and Outer Enamel Epithelium. Stem Cells Dev. 2016, 25, 1580–1590. [Google Scholar] [CrossRef]
  112. Inubushi, T.; Nag, P.; Sasaki, J.I.; Shiraishi, Y.; Yamashiro, T. The significant role of glycosaminoglycans in tooth development. Glycobiology 2024, 34, cwae024. [Google Scholar] [CrossRef]
  113. Thesleff, I.; Sharpe, P. Signalling networks regulating dental development. Mech. Dev. 1997, 67, 111–123. [Google Scholar] [CrossRef]
  114. Liu, F.; Chu, E.Y.; Watt, B.; Zhang, Y.; Gallant, N.M.; Andl, T.; Yang, S.H.; Lu, M.M.; Piccolo, S.; Schmidt-Ullrich, R.; et al. Wnt/beta-catenin signaling directs multiple stages of tooth morphogenesis. Dev. Biol. 2008, 313, 210–224. [Google Scholar] [CrossRef]
  115. Jarvinen, E.; Salazar-Ciudad, I.; Birchmeier, W.; Taketo, M.M.; Jernvall, J.; Thesleff, I. Continuous tooth generation in mouse is induced by activated epithelial Wnt/beta-catenin signaling. Proc. Natl. Acad. Sci. USA 2006, 103, 18627–18632. [Google Scholar] [CrossRef]
  116. Guan, X.; Xu, M.; Millar, S.E.; Bartlett, J.D. Beta-catenin is essential for ameloblast movement during enamel development. Eur. J. Oral Sci. 2016, 124, 221–227. [Google Scholar] [CrossRef]
  117. Fausser, J.L.; Schlepp, O.; Aberdam, D.; Meneguzzi, G.; Ruch, J.V.; Lesot, H. Localization of antigens associated with adherens junctions, desmosomes, and hemidesmosomes during murine molar morphogenesis. Differentiation 1998, 63, 1–11. [Google Scholar] [CrossRef] [PubMed]
  118. Sorkin, B.C.; Wang, M.Y.; Dobeck, J.M.; Albergo, K.L.; Skobe, Z. The cadherin-catenin complex is expressed alternately with the adenomatous polyposis coli protein during rat incisor amelogenesis. J. Histochem. Cytochem. 2000, 48, 397–406. [Google Scholar] [CrossRef]
  119. Cho, A.; Haruyama, N.; Hall, B.; Danton, M.J.; Zhang, L.; Arany, P.; Mooney, D.J.; Harichane, Y.; Goldberg, M.; Gibson, C.W.; et al. TGF-ss regulates enamel mineralization and maturation through KLK4 expression. PLoS ONE 2013, 8, e82267. [Google Scholar] [CrossRef]
  120. Yokozeki, M.; Afanador, E.; Nishi, M.; Kaneko, K.; Shimokawa, H.; Yokote, K.; Deng, C.; Tsuchida, K.; Sugino, H.; Moriyama, K. Smad3 is required for enamel biomineralization. Biochem. Biophys. Res. Commun. 2003, 305, 684–690. [Google Scholar] [CrossRef]
  121. Gao, Y.; Li, D.; Han, T.; Sun, Y.; Zhang, J. TGF-beta1 and TGFBR1 are expressed in ameloblasts and promote MMP20 expression. Anat. Rec. 2009, 292, 885–890. [Google Scholar] [CrossRef] [PubMed]
  122. Okubo, M.; Chiba, R.; Karakida, T.; Yamazaki, H.; Yamamoto, R.; Kobayashi, S.; Niwa, T.; Margolis, H.C.; Nagano, T.; Yamakoshi, Y.; et al. Potential function of TGF-beta isoforms in maturation-stage ameloblasts. J. Oral Biosci. 2019, 61, 43–54. [Google Scholar] [CrossRef] [PubMed]
  123. Hyun, S.Y.; Mun, S.; Kang, K.J.; Lim, J.C.; Kim, S.Y.; Han, K.; Jang, Y.J. Amelogenic transcriptome profiling in ameloblast-like cells derived from adult gingival epithelial cells. Sci. Rep. 2019, 9, 3736. [Google Scholar] [CrossRef]
  124. Huang, X.; Xu, X.; Bringas, P., Jr.; Hung, Y.P.; Chai, Y. Smad4-Shh-Nfic signaling cascade-mediated epithelial-mesenchymal interaction is crucial in regulating tooth root development. J. Bone Miner Res. 2010, 25, 1167–1178. [Google Scholar] [CrossRef]
  125. Takamori, K.; Hosokawa, R.; Xu, X.; Deng, X.; Bringas, P., Jr.; Chai, Y. Epithelial fibroblast growth factor receptor 1 regulates enamel formation. J. Dent. Res. 2008, 87, 238–243. [Google Scholar] [CrossRef] [PubMed]
  126. Mitsiadis, T.A.; Graf, D.; Luder, H.; Gridley, T.; Bluteau, G. BMPs and FGFs target Notch signalling via jagged 2 to regulate tooth morphogenesis and cytodifferentiation. Development 2010, 137, 3025–3035. [Google Scholar] [CrossRef]
  127. Li, C.Y.; Prochazka, J.; Goodwin, A.F.; Klein, O.D. Fibroblast growth factor signaling in mammalian tooth development. Odontology 2014, 102, 1–13. [Google Scholar] [CrossRef]
  128. Greenblatt, M.B.; Kim, J.M.; Oh, H.; Park, K.H.; Choo, M.K.; Sano, Y.; Tye, C.E.; Skobe, Z.; Davis, R.J.; Park, J.M.; et al. p38alpha MAPK is required for tooth morphogenesis and enamel secretion. J. Biol. Chem. 2015, 290, 284–295. [Google Scholar] [CrossRef] [PubMed]
  129. Goodwin, A.F.; Tidyman, W.E.; Jheon, A.H.; Sharir, A.; Zheng, X.; Charles, C.; Fagin, J.A.; McMahon, M.; Diekwisch, T.G.; Ganss, B.; et al. Abnormal Ras signaling in Costello syndrome (CS) negatively regulates enamel formation. Hum. Mol. Genet. 2014, 23, 682–692. [Google Scholar] [CrossRef]
  130. Gritli-Linde, A.; Bei, M.; Maas, R.; Zhang, X.M.; Linde, A.; McMahon, A.P. Shh signaling within the dental epithelium is necessary for cell proliferation, growth and polarization. Development 2002, 129, 5323–5337. [Google Scholar] [CrossRef] [PubMed]
  131. Hosoya, A.; Shalehin, N.; Takebe, H.; Shimo, T.; Irie, K. Sonic Hedgehog Signaling and Tooth Development. Int. J. Mol. Sci. 2020, 21, 1587. [Google Scholar] [CrossRef]
  132. Yasukawa, M.; Ishida, K.; Yuge, Y.; Hanaoka, M.; Minami, Y.; Ogawa, M.; Sasaki, T.; Saito, M.; Tsuji, T. Dpysl4 is involved in tooth germ morphogenesis through growth regulation, polarization and differentiation of dental epithelial cells. Int. J. Biol. Sci. 2013, 9, 382–390. [Google Scholar] [CrossRef]
  133. Hermans, F.; Hemeryck, L.; Lambrichts, I.; Bronckaers, A.; Vankelecom, H. Intertwined Signaling Pathways Governing Tooth Development: A Give-and-Take Between Canonical Wnt and Shh. Front. Cell Dev. Biol. 2021, 9, 758203. [Google Scholar] [CrossRef]
  134. Hatakeyama, J.; Fukumoto, S.; Nakamura, T.; Haruyama, N.; Suzuki, S.; Hatakeyama, Y.; Shum, L.; Gibson, C.W.; Yamada, Y.; Kulkarni, A.B. Synergistic roles of amelogenin and ameloblastin. J. Dent. Res. 2009, 88, 318–322. [Google Scholar] [CrossRef]
  135. Nishikawa, S. Cytoskeleton, intercellular junctions, planar cell polarity, and cell movement in amelogenesis. J. Oral Biosci. 2017, 59, 197–204. [Google Scholar] [CrossRef]
  136. Lee, H.K.; Lee, D.S.; Ryoo, H.M.; Park, J.T.; Park, S.J.; Bae, H.S.; Cho, M.I.; Park, J.C. The odontogenic ameloblast-associated protein (ODAM) cooperates with RUNX2 and modulates enamel mineralization via regulation of MMP-20. J. Cell Biochem. 2010, 111, 755–767. [Google Scholar] [CrossRef]
  137. Chu, Q.; Gao, Y.; Gao, X.; Dong, Z.; Song, W.; Xu, Z.; Xiang, L.; Wang, Y.; Zhang, L.; Li, M.; et al. Ablation of Runx2 in Ameloblasts Suppresses Enamel Maturation in Tooth Development. Sci. Rep. 2018, 8, 9594. [Google Scholar] [CrossRef] [PubMed]
  138. Kanchan, T.; Machado, M.; Rao, A.; Krishan, K.; Garg, A.K. Enamel hypoplasia and its role in identification of individuals: A review of literature. Indian J. Dent. 2015, 6, 99–102. [Google Scholar] [CrossRef]
  139. Modrić, V.E.; Verzak, Ž.; Karlović, Z. Developmental Defects of Enamel in Children with Intellectual Disability. Acta Stomatol. Croat. 2016, 50, 65–71. [Google Scholar]
  140. Kierdorf, U.; Death, C.; Hufschmid, J.; Witzel, C.; Kierdorf, H. Developmental and Post-Eruptive Defects in Molar Enamel of Free-Ranging Eastern Grey Kangaroos (Macropus giganteus) Exposed to High Environmental Levels of Fluoride. PLoS ONE 2016, 11, e0147427. [Google Scholar] [CrossRef] [PubMed]
  141. Hubbard, M.J.; Mangum, J.E.; Perez, V.A.; Nervo, G.J.; Hall, R.K. Molar Hypomineralisation: A Call to Arms for Enamel Researchers. Front. Physiol. 2017, 8, 546. [Google Scholar] [CrossRef]
  142. Wang, S.K.; Zhang, H.; Lin, H.C.; Wang, Y.L.; Lin, S.C.; Seymen, F.; Koruyucu, M.; Simmer, J.P.; Hu, J.C. AMELX Mutations and Genotype-Phenotype Correlation in X-Linked Amelogenesis Imperfecta. Int. J. Mol. Sci. 2024, 25, 6132. [Google Scholar] [CrossRef] [PubMed]
  143. Hu, J.C.; Yamakoshi, Y. Enamelin and autosomal-dominant amelogenesis imperfecta. Crit. Rev. Oral Biol. Med. 2003, 14, 387–398. [Google Scholar] [CrossRef]
  144. Hart, P.S.; Michalec, M.D.; Seow, W.K.; Hart, T.C.; Wright, J.T. Identification of the enamelin (g.8344delG) mutation in a new kindred and presentation of a standardized ENAM nomenclature. Arch. Oral Biol. 2003, 48, 589–596. [Google Scholar] [CrossRef]
  145. Wang, Y.L.; Lin, H.C.; Liang, T.; Lin, J.C.; Simmer, J.P.; Hu, J.C.; Wang, S.K. ENAM Mutations Can Cause Hypomaturation Amelogenesis Imperfecta. J. Dent. Res. 2024, 103, 662–671. [Google Scholar] [CrossRef]
  146. Ozdemir, D.; Hart, P.S.; Ryu, O.H.; Choi, S.J.; Ozdemir-Karatas, M.; Firatli, E.; Piesco, N.; Hart, T.C. MMP20 active-site mutation in hypomaturation amelogenesis imperfecta. J. Dent. Res. 2005, 84, 1031–1035. [Google Scholar] [CrossRef]
  147. Kim, Y.J.; Kang, J.; Seymen, F.; Koruyucu, M.; Gencay, K.; Shin, T.J.; Hyun, H.K.; Lee, Z.H.; Hu, J.C.; Simmer, J.P.; et al. Analyses of MMP20 Missense Mutations in Two Families with Hypomaturation Amelogenesis Imperfecta. Front. Physiol. 2017, 8, 229. [Google Scholar] [CrossRef]
  148. Lee, Y.; Zhang, H.; Seymen, F.; Kim, Y.J.; Kasimoglu, Y.; Koruyucu, M.; Simmer, J.P.; Hu, J.C.; Kim, J.W. Novel KLK4 Mutations Cause Hypomaturation Amelogenesis Imperfecta. J. Pers. Med. 2022, 12, 150. [Google Scholar] [CrossRef] [PubMed]
  149. Kim, Y.J.; Zhang, H.; Lee, Y.; Seymen, F.; Koruyucu, M.; Kasimoglu, Y.; Simmer, J.P.; Hu, J.C.; Kim, J.W. Novel WDR72 Mutations Causing Hypomaturation Amelogenesis Imperfecta. J. Pers. Med. 2023, 13, 326. [Google Scholar] [CrossRef] [PubMed]
  150. Katsura, K.; Nakano, Y.; Zhang, Y.; Shemirani, R.; Li, W.; Den Besten, P. WDR72 regulates vesicle trafficking in ameloblasts. Sci. Rep. 2022, 12, 2820. [Google Scholar] [CrossRef]
  151. Parry, D.A.; Poulter, J.A.; Logan, C.V.; Brookes, S.J.; Jafri, H.; Ferguson, C.H.; Anwari, B.M.; Rashid, Y.; Zhao, H.; Johnson, C.A. Identification of mutations in SLC24A4, encoding a potassium-dependent sodium/calcium exchanger, as a cause of amelogenesis imperfecta. Am. J. Hum. Genet. 2013, 92, 307–312. [Google Scholar] [CrossRef]
  152. Wang, S.K.; Reid, B.M.; Dugan, S.L.; Roggenbuck, J.A.; Read, L.; Aref, P.; Taheri, A.P.; Yeganeh, M.Z.; Simmer, J.P.; Hu, J.C. FAM20A mutations associated with enamel renal syndrome. J. Dent. Res. 2014, 93, 42–48. [Google Scholar] [CrossRef] [PubMed]
  153. Bloch-Zupan, A.; Rey, T.; Jimenez-Armijo, A.; Kawczynski, M.; Kharouf, N.; O-Rare Consortium; Dure-Molla, M.; Noirrit, E.; Hernandez, M.; Joseph-Beaudin, C.; et al. Amelogenesis imperfecta: Next-generation sequencing sheds light on Witkop’s classification. Front. Physiol. 2023, 14, 1130175. [Google Scholar]
  154. DenBesten, P.; Li, W. Chronic fluoride toxicity: Dental fluorosis. Monogr. Oral Sci. 2011, 22, 81–96. [Google Scholar]
  155. Shahroom, N.S.B.; Mani, G.; Ramakrishnan, M. Interventions in management of dental fluorosis, an endemic disease: A systematic review. J. Family Med. Prim. Care 2019, 8, 3108–3113. [Google Scholar] [PubMed]
  156. Aoba, T.; Fejerskov, O. Dental fluorosis: Chemistry and biology. Crit. Rev. Oral Biol. Med. 2002, 13, 155–170. [Google Scholar] [CrossRef]
  157. Weerheijm, K.L. Molar incisor hypomineralisation (MIH). Eur. J. Paediatr. Dent. 2003, 4, 114–120. [Google Scholar]
  158. Silva, M.J.; Scurrah, K.J.; Craig, J.M.; Manton, D.J.; Kilpatrick, N. Etiology of molar incisor hypomineralization—A systematic review. Community Dent. Oral Epidemiol. 2016, 44, 342–353. [Google Scholar] [CrossRef]
  159. Goodman, A.H.; Rose, J.C. Assessment of systemic physiological perturbations from dental enamel hypoplasias and associated histological structures. Am. J. Phys. Anthropol. 1990, 33, 59–110. [Google Scholar] [CrossRef]
  160. Seow, W.K.; Humphrys, C.; Tudehope, D.I. Increased prevalence of developmental dental defects in low birth-weight, prematurely born children: A controlled study. Pediatr. Dent. 1987, 9, 221–225. [Google Scholar]
  161. Almuallem, Z.; Busuttil-Naudi, A. Molar incisor hypomineralisation (MIH)—An overview. Br. Dent. J. 2018, 225, 601–609. [Google Scholar] [CrossRef]
  162. Davari, A.; Ataei, E.; Assarzadeh, H. Dentin hypersensitivity: Etiology, diagnosis and treatment; a literature review. J. Dent. 2013, 14, 136–145. [Google Scholar]
  163. Lygidakis, N.A.; Garot, E.; Somani, C.; Taylor, G.D.; Rouas, P.; Wong, F.S.L. Best clinical practice guidance for clinicians dealing with children presenting with molar-incisor-hypomineralisation (MIH): An updated European Academy of Paediatric Dentistry policy document. Eur. Arch. Paediatr. Dent. 2022, 23, 3–21. [Google Scholar] [CrossRef]
  164. Lagarde, M.; Vennat, E.; Attal, J.P.; Dursun, E. Strategies to optimize bonding of adhesive materials to molar-incisor hypomineralization-affected enamel: A systematic review. Int. J. Paediatr. Dent. 2020, 30, 405–420. [Google Scholar] [CrossRef] [PubMed]
  165. Pini, N.I.; Sundfeld-Neto, D.; Aguiar, F.H.; Sundfeld, R.H.; Martins, L.R.; Lovadino, J.R.; Lima, D.A. Enamel microabrasion: An overview of clinical and scientific considerations. World J. Clin. Cases 2015, 3, 34–41. [Google Scholar] [CrossRef]
  166. Chen, C.F.; Hu, J.C.; Bresciani, E.; Peters, M.C.; Estrella, M.R. Treatment considerations for patient with Amelogenesis Imperfecta: A review. Braz. Dent. Sci. 2013, 16, 7–18. [Google Scholar] [CrossRef]
  167. Pousette Lundgren, G.; Dahllof, G. Advances in clinical diagnosis and management of amelogenesis imperfecta in children and adolescents. J. Dent. 2024, 147, 105149. [Google Scholar] [CrossRef]
  168. Chan, B.; Cheng, I.C.; Rozita, J.; Gorshteyn, I.; Huang, Y.; Shaffer, I.; Chang, C.; Li, W.; Lytton, J.; Den Besten, P.; et al. Sodium/(calcium + potassium) exchanger NCKX4 optimizes KLK4 activity in the enamel matrix microenvironment to regulate ECM modeling. Front. Physiol. 2023, 14, 1116091. [Google Scholar] [CrossRef] [PubMed]
  169. Bronckers, A.L.; Lyaruu, D.M.; Guo, J.; Bijvelds, M.J.; Bervoets, T.J.; Zandieh-Doulabi, B.; Medina, J.F.; Li, Z.; Zhang, Y.; DenBesten, P.K. Composition of mineralizing incisor enamel in cystic fibrosis transmembrane conductance regulator-deficient mice. Eur. J. Oral Sci. 2015, 123, 9–16. [Google Scholar] [CrossRef] [PubMed]
  170. Ngu, J.; Bronckers, A.L.J.J.; Katsura, K.; Zhang, Y.; Den Besten, P.K. Na+ and K+ transport and maturation stage ameloblast modulation. Front. Physiol. 2023, 14, 1124444. [Google Scholar] [CrossRef]
  171. Josephsen, K.; Takano, Y.; Frische, S.; Praetorius, J.; Nielsen, S.; Aoba, T.; Fejerskov, O. Ion transporters in secretory and cyclically modulating ameloblasts: A new hypothesis for cellular control of preeruptive enamel maturation. Am. J. Physiol. Cell Physiol. 2010, 299, C1299–C1307. [Google Scholar] [CrossRef]
  172. Sasaki, S.; Takagi, T.; Suzuki, M. Cyclical changes in pH in bovine developing enamel as sequential bands. Arch. Oral Biol. 1991, 36, 227–231. [Google Scholar] [CrossRef]
  173. Nurbaeva, M.K.; Eckstein, M.; Concepcion, A.R.; Smith, C.E.; Srikanth, S.; Paine, M.L.; Gwack, Y.; Hubbard, M.J.; Feske, S.; Lacruz, R.S. Dental enamel cells express functional SOCE channels. Sci. Rep. 2015, 5, 15803. [Google Scholar] [CrossRef]
  174. Wen, X.; Lacruz, R.S.; Smith, C.E.; Paine, M.L. Gene-expression profile and localization of Na+/K+-ATPase in rat enamel organ cells. Eur. J. Oral Sci. 2014, 122, 21–26. [Google Scholar] [CrossRef] [PubMed]
  175. Jalali, R.; Lodder, J.C.; Zandieh-Doulabi, B.; Micha, D.; Melvin, J.E.; Catalan, M.A.; Mansvelder, H.D.; DenBesten, P.; Bronckers, A. The Role of Na:K:2Cl Cotransporter 1 (NKCC1/SLC12A2) in Dental Epithelium during Enamel Formation in Mice. Front. Physiol. 2017, 8, 924. [Google Scholar] [CrossRef] [PubMed]
  176. Garant, P.R.; Sasaki, T.; Colflesh, P.E. Na-K-ATPase in the enamel organ: Localization and possible roles in enamel formation. Adv. Dent. Res. 1987, 1, 267–275. [Google Scholar] [CrossRef]
  177. Bori, E.; Guo, J.; Rácz, R.; Burghardt, B.; Földes, A.; Kerémi, B.; Harada, H.; Steward, M.C.; Den Besten, P.; Bronckers, A.L.; et al. Evidence for Bicarbonate Secretion by Ameloblasts in a Novel Cellular Model. J. Dent. Res. 2016, 95, 588–596. [Google Scholar] [CrossRef]
  178. Eckstein, M.; Vaeth, M.; Aulestia, F.J.; Costiniti, V.; Kassam, S.N.; Bromage, T.G.; Pedersen, P.; Issekutz, T.; Idaghdour, Y.; Moursi, A.M.; et al. Differential regulation of Ca2+ influx by ORAI channels mediates enamel mineralization. Sci. Signal 2019, 12, eaav4663. [Google Scholar] [CrossRef]
  179. Lacruz, R.S.; Nanci, A.; White, S.N.; Wen, X.; Wang, H.; Zalzal, S.F.; Luong, V.Q.; Schuetter, V.L.; Conti, P.S.; Kurtz, I.; et al. The sodium bicarbonate cotransporter (NBCe1) is essential for normal development of mouse dentition. J. Biol. Chem. 2010, 285, 24432–24438. [Google Scholar] [CrossRef]
  180. Wen, X.; Kurtz, I.; Paine, M.L. Prevention of the disrupted enamel phenotype in Slc4a4-null mice using explant organ culture maintained in a living host kidney capsule. PLoS ONE 2014, 9, e97318. [Google Scholar] [CrossRef] [PubMed]
  181. O’Leary, F.; Coffey, N.; Hayes, M.; Burke, F.; Harding, M.; Plant, B. The prevalence of developmental defects of enamel in people with cystic fibrosis: A systematic review. BMC Oral Health 2024, 24, 446. [Google Scholar] [CrossRef]
  182. Chang, E.H.; Lacruz, R.S.; Bromage, T.G.; Bringas, P., Jr.; Welsh, M.J.; Zabner, J.; Paine, M.L. Enamel pathology resulting from loss of function in the cystic fibrosis transmembrane conductance regulator in a porcine animal model. Cells Tissues Organs 2011, 194, 249–254. [Google Scholar] [CrossRef]
  183. Luder, H.U.; Gerth-Kahlert, C.; Ostertag-Benzinger, S.; Schorderet, D.F. Dental phenotype in Jalili syndrome due to a c.1312 dupC homozygous mutation in the CNNM4 gene. PLoS ONE 2013, 8, e78529. [Google Scholar] [CrossRef]
  184. Yamazaki, D.; Funato, Y.; Miura, J.; Sato, S.; Toyosawa, S.; Furutani, K.; Kurachi, Y.; Omori, Y.; Furukawa, T.; Tsuda, T.; et al. Basolateral Mg2+ extrusion via CNNM4 mediates transcellular Mg2+ transport across epithelia: A mouse model. PLoS Genet. 2013, 9, e1003983. [Google Scholar] [CrossRef]
  185. Ogata, K.; Tsumuraya, T.; Oka, K.; Shin, M.; Okamoto, F.; Kajiya, H.; Katagiri, C.; Ozaki, M.; Matsushita, M.; Okabe, K. The crucial role of the TRPM7 kinase domain in the early stage of amelogenesis. Sci. Rep. 2017, 7, 18099. [Google Scholar] [CrossRef]
  186. Nurbaeva, M.K.; Eckstein, M.; Feske, S.; Lacruz, R.S. Ca2+ transport and signalling in enamel cells. J. Physiol. 2017, 595, 3015–3039. [Google Scholar] [CrossRef] [PubMed]
  187. Zheng, L.; Zinn, V.; Lefkelidou, A.; Taqi, N.; Chatzistavrou, X.; Balam, T.; Nervina, J.; Papagerakis, S.; Papagerakis, P. Orai1 expression pattern in tooth and craniofacial ectodermal tissues and potential functions during ameloblast differentiation. Dev. Dyn. 2015, 244, 1249–1258. [Google Scholar] [CrossRef] [PubMed]
  188. Berdal, A.; Nanci, A.; Smith, C.E.; Ahluwalia, J.P.; Thomasset, M.; Cuisinier-Gleizes, P.; Mathieu, H. Differential expression of calbindin-D 28 kDa in rat incisor ameloblasts throughout enamel development. Anat. Rec. 1991, 230, 149–163. [Google Scholar] [CrossRef]
  189. Bailleul-Forestier, I.; Davideau, J.L.; Papagerakis, P.; Noble, I.; Nessmann, C.; Peuchmaur, M.; Berdal, A. Immunolocalization of vitamin D receptor and calbindin-D28k in human tooth germ. Pediatr. Res. 1996, 39 Pt 1, 636–642. [Google Scholar] [CrossRef]
  190. Sasaki, T.; Garant, P.R. Calmodulin in rat incisor secretory ameloblasts as revealed by protein A-gold immunocytochemistry. Calcif. Tissue Int. 1987, 40, 294–297. [Google Scholar] [CrossRef]
  191. Davideau, J.L.; Celio, M.R.; Hotton, D.; Berdal, A. Developmental pattern and subcellular localization of parvalbumin in the rat tooth germ. Arch. Oral Biol. 1993, 38, 707–715. [Google Scholar] [CrossRef] [PubMed]
  192. Onishi, T.; Ooshima, T.; Sobue, S.; Tabata, M.J.; Kurisu, K.; Wakisaka, S. Calbindin D28k-like immunoreactivity during the formation of the enamel-free area in the rat molar teeth. Anat. Rec. 2000, 258, 384–390. [Google Scholar] [CrossRef]
  193. Bawden, J.W.; Wennberg, A. In vitro study of cellular influence on 45Ca uptake in developing rat enamel. J. Dent. Res. 1977, 56, 313–319. [Google Scholar] [CrossRef]
  194. Wennberg, A.; Bawden, J.W. Comparison of 33P with 45Ca distribution in developing rat molar enamel in vivo and in vitro. J. Dent. Res. 1978, 57, 111–117. [Google Scholar] [CrossRef]
  195. Kawamoto, T.; Shimizu, M. Pathway and speed of calcium movement from blood to mineralizing enamel. J. Histochem. Cytochem. 1997, 45, 213–230. [Google Scholar] [CrossRef]
  196. Souza Bomfim, G.H.; Mitaishvili, E.; Schnetkamp, P.P.M.; Lacruz, R.S. Na+/Ca2+ exchange in enamel cells is dominated by the K+-dependent NCKX exchanger. J. Gen. Physiol. 2024, 156. [Google Scholar] [CrossRef]
  197. Okumura, R.; Shibukawa, Y.; Muramatsu, T.; Hashimoto, S.; Nakagawa, K.; Tazaki, M.; Shimono, M. Sodium-calcium exchangers in rat ameloblasts. J. Pharmacol. Sci. 2010, 112, 223–230. [Google Scholar] [CrossRef]
  198. Robertson, S.Y.T.; Wen, X.; Yin, K.; Chen, J.; Smith, C.E.; Paine, M.L. Multiple Calcium Export Exchangers and Pumps Are a Prominent Feature of Enamel Organ Cells. Front. Physiol. 2017, 8, 336. [Google Scholar] [CrossRef] [PubMed]
  199. Stafford, N.; Wilson, C.; Oceandy, D.; Neyses, L.; Cartwright, E.J. The Plasma Membrane Calcium ATPases and Their Role as Major New Players in Human Disease. Physiol. Rev. 2017, 97, 1089–1125. [Google Scholar] [CrossRef]
  200. Hu, P.; Lacruz, R.S.; Smith, C.E.; Smith, S.M.; Kurtz, I.; Paine, M.L. Expression of the sodium/calcium/potassium exchanger, NCKX4, in ameloblasts. Cells Tissues Organs 2012, 196, 501–509. [Google Scholar] [CrossRef] [PubMed]
  201. Bronckers, A.L.; Jalali, R.; Lytton, J. Reduced Protein Expression of the Na+/Ca2++K+-Exchanger (SLC24A4) in Apical Plasma Membranes of Maturation Ameloblasts of Fluorotic Mice. Calcif. Tissue Int. 2017, 100, 80–86. [Google Scholar] [CrossRef] [PubMed]
  202. Said, R.; Lobanova, L.; Papagerakis, S.; Papagerakis, P. Calcium Sets the Clock in Ameloblasts. Front. Physiol. 2020, 11, 920. [Google Scholar] [CrossRef]
  203. Rui, H.; Das, A.; Nakamoto, R.; Roux, B. Proton Countertransport and Coupled Gating in the Sarcoplasmic Reticulum Calcium Pump. J. Mol. Biol. 2018, 430, 5050–5065. [Google Scholar] [CrossRef] [PubMed]
  204. Jacobsen, N.J.; Lyons, I.; Hoogendoorn, B.; Burge, S.; Kwok, P.Y.; O’Donovan, M.C.; Craddock, N.; Owen, M.J. ATP2A2 mutations in Darier’s disease and their relationship to neuropsychiatric phenotypes. Hum. Mol. Genet. 1999, 8, 1631–1636. [Google Scholar] [CrossRef] [PubMed]
  205. Hovnanian, A. Darier’s disease: From dyskeratosis to endoplasmic reticulum calcium ATPase deficiency. Biochem. Biophys. Res. Commun. 2004, 322, 1237–1244. [Google Scholar] [CrossRef] [PubMed]
  206. Xue, J.; Zeng, W.; Han, Y.; John, S.; Ottolia, M.; Jiang, Y. Structural mechanisms of the human cardiac sodium-calcium exchanger NCX1. Nat. Commun. 2023, 14, 6181. [Google Scholar] [CrossRef]
  207. Paine, M.L.; Snead, M.L.; Wang, H.J.; Abuladze, N.; Pushkin, A.; Liu, W.; Kao, L.Y.; Wall, S.M.; Kim, Y.H.; Kurtz, I. Role of NBCe1 and AE2 in secretory ameloblasts. J. Dent. Res. 2008, 87, 391–395. [Google Scholar] [CrossRef]
  208. Chen, L.M.; Liu, Y.; Boron, W.F. Role of an extracellular loop in determining the stoichiometry of Na+-HCO3 cotransporters. J. Physiol. 2011, 589 Pt 4, 877–890. [Google Scholar] [CrossRef]
  209. Lacruz, R.S.; Hilvo, M.; Kurtz, I.; Paine, M.L. A survey of carbonic anhydrase mRNA expression in enamel cells. Biochem. Biophys. Res. Commun. 2010, 393, 883–887. [Google Scholar] [CrossRef]
  210. Reibring, C.G.; El Shahawy, M.; Hallberg, K.; Kannius-Janson, M.; Nilsson, J.; Parkkila, S.; Sly, W.S.; Waheed, A.; Linde, A.; Gritli-Linde, A. Expression patterns and subcellular localization of carbonic anhydrases are developmentally regulated during tooth formation. PLoS ONE 2014, 9, e96007. [Google Scholar] [CrossRef]
  211. Leite, L.D.R.; Resende, K.K.M.; Rosa, L.D.S.; Mazzeu, J.F.; de Oliveira, L.C.; Scher, M.D.C.S.D.; Acevedo, A.C.; Yamaguti, P.M. Carbonic anhydrase II deficiency syndrome with amelogenesis imperfecta linked to a homozygous CA2 deletion. Intractable Rare Dis. Res. 2023, 12, 202–205. [Google Scholar] [CrossRef]
  212. Racz, R.; Földes, A.; Bori, E.; Zsembery, Á.; Harada, H.; Steward, M.C.; DenBesten, P.; Bronckers, A.L.J.J.; Gerber, G.; Varga, G. No Change in Bicarbonate Transport but Tight-Junction Formation Is Delayed by Fluoride in a Novel Ameloblast Model. Front. Physiol. 2017, 8, 940. [Google Scholar] [CrossRef]
  213. Wright, J.T.; Kiefer, C.L.; Hall, K.I.; Grubb, B.R. Abnormal enamel development in a cystic fibrosis transgenic mouse model. J. Dent. Res. 1996, 75, 966–973. [Google Scholar] [CrossRef]
  214. Jalali, R.; Zandieh-Doulabi, B.; DenBesten, P.K.; Seidler, U.; Riederer, B.; Wedenoja, S.; Micha, D.; Bronckers, A.L. Slc26a3/Dra and Slc26a6 in Murine Ameloblasts. J. Dent. Res. 2015, 94, 1732–1739. [Google Scholar] [CrossRef]
  215. Bronckers, A.L.; Guo, J.; Zandieh-Doulabi, B.; Bervoets, T.J.; Lyaruu, D.M.; Li, X.; Wangemann, P.; DenBesten, P. Developmental expression of solute carrier family 26A member 4 (SLC26A4/pendrin) during amelogenesis in developing rodent teeth. Eur. J. Oral Sci. 2011, 119 (Suppl. S1), 185–192. [Google Scholar] [CrossRef]
  216. Ko, S.B.; Zeng, W.; Dorwart, M.R.; Luo, X.; Kim, K.H.; Millen, L.; Goto, H.; Naruse, S.; Soyombo, A.; Thomas, P.J.; et al. Gating of CFTR by the STAS domain of SLC26 transporters. Nat. Cell Biol. 2004, 6, 343–350. [Google Scholar] [CrossRef]
  217. Yin, K.; Guo, J.; Lin, W.; Robertson, S.Y.T.; Soleimani, M.; Paine, M.L. Deletion of Slc26a1 and Slc26a7 Delays Enamel Mineralization in Mice. Front. Physiol. 2017, 8, 307. [Google Scholar] [CrossRef]
  218. Sarkar, J.; Wen, X.; Simanian, E.J.; Paine, M.L. V-type ATPase proton pump expression during enamel formation. Matrix Biol. 2016, 52–54, 234–245. [Google Scholar] [CrossRef]
  219. Varga, G.; DenBesten, P.; Rácz, R.; Zsembery, Á. Importance of bicarbonate transport in pH control during amelogenesis—Need for functional studies. Oral Dis. 2018, 24, 879–890. [Google Scholar] [CrossRef]
  220. Johnson, L.; Ganss, B.; Wang, A.; Zirngibl, R.A.; Johnson, D.E.; Owen, C.; Bradley, G.; Voronov, I. V-ATPases Containing a3 Subunit Play a Direct Role in Enamel Development in Mice. J. Cell. Biochem. 2017, 118, 3328–3340. [Google Scholar] [CrossRef] [PubMed]
  221. Foldes, A.; Sang-Ngoen, T.; Kádár, K.; Rácz, R.; Zsembery, Á.; DenBesten, P.; Steward, M.C.; Varga, G. Three-Dimensional Culture of Ameloblast-Originated HAT-7 Cells for Functional Modeling of Defective Tooth Enamel Formation. Front. Pharmacol. 2021, 12, 682654. [Google Scholar] [CrossRef] [PubMed]
  222. Slepkov, E.R.; Rainey, J.K.; Sykes, B.D.; Fliegel, L. Structural and functional analysis of the Na+/H+ exchanger. Biochem. J. 2007, 401, 623–633. [Google Scholar] [CrossRef] [PubMed]
  223. Parry, D.A.; Mighell, A.J.; El-Sayed, W.; Shore, R.C.; Jalili, I.K.; Dollfus, H.; Bloch-Zupan, A.; Carlos, R.; Carr, I.M.; Downey, L.M. Mutations in CNNM4 cause Jalili syndrome, consisting of autosomal-recessive cone-rod dystrophy and amelogenesis imperfecta. Am. J. Hum. Genet. 2009, 84, 266–273. [Google Scholar] [CrossRef]
  224. Gunther, T.; Vormann, J.; Hollriegl, V. Characterization of Na+-dependent Mg2+ efflux from Mg2+-loaded rat erythrocytes. Biochim. Biophys. Acta 1990, 1023, 455–461. [Google Scholar] [CrossRef] [PubMed]
  225. Kadar, K.; Juhász, V.; Földes, A.; Rácz, R.; Zhang, Y.; Löchli, H.; Kató, E.; Köles, L.; Steward, M.C.; DenBesten, P.; et al. TRPM7-Mediated Calcium Transport in HAT-7 Ameloblasts. Int. J. Mol. Sci. 2021, 22, 3992. [Google Scholar] [CrossRef] [PubMed]
  226. Shin, M.; Matsushima, A.; Kajiya, H.; Okamoto, F.; Ogata, K.; Oka, K.; Ohshima, H.; Bartlett, J.D.; Okabe, K. Conditional knockout of transient receptor potential melastatin 7 in the enamel epithelium: Effects on enamel formation. Eur. J. Oral Sci. 2023, 131, e12920. [Google Scholar] [CrossRef]
  227. Nakano, Y.; Le, M.H.; Abduweli, D.; Ho, S.P.; Ryazanova, L.V.; Hu, Z.; Ryazanov, A.G.; Den Besten, P.K.; Zhang, Y. A Critical Role of TRPM7 As an Ion Channel Protein in Mediating the Mineralization of the Craniofacial Hard Tissues. Front. Physiol. 2016, 7, 258. [Google Scholar] [CrossRef]
  228. Millan, J.L.; Whyte, M.P. Alkaline Phosphatase and Hypophosphatasia. Calcif. Tissue Int. 2016, 98, 398–416. [Google Scholar] [CrossRef]
  229. Irizarry, A.R.; Yan, G.; Zeng, Q.; Lucchesi, J.; Hamang, M.J.; Ma, Y.L.; Rong, J.X. Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient mice. PLoS ONE 2017, 12, e0175465. [Google Scholar] [CrossRef] [PubMed]
  230. Bhutia, Y.D.; Kopel, J.J.; Lawrence, J.J.; Neugebauer, V.; Ganapathy, V. Plasma Membrane Na+-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy. Molecules 2017, 22, 378. [Google Scholar] [CrossRef]
  231. Hu, J.C.; Liang, T.; Zhang, H.; Hu, Y.; Yamakoshi, Y.; Yamamoto, R.; Zhang, C.; Li, H.; Smith, C.E.; Simmer, J.P. Citrate Transporter Expression and Localization: The Slc13a5(Flag) Mouse Model. Int. J. Mol. Sci. 2025, 26, 6707. [Google Scholar] [CrossRef]
  232. Yadav, M.C.; de Oliveira, R.C.; Foster, B.L.; Fong, H.; Cory, E.; Narisawa, S.; Sah, R.L.; Somerman, M.; Whyte, M.P.; Millán, J.L. Enzyme replacement prevents enamel defects in hypophosphatasia mice. J. Bone Miner Res. 2012, 27, 1722–1734. [Google Scholar] [CrossRef]
  233. Whyte, M.P. Hypophosphatasia: An overview for 2017. Bone 2017, 102, 15–25. [Google Scholar] [CrossRef]
  234. Giovannini, D.; Touhami, J.; Charnet, P.; Sitbon, M.; Battini, J.L. Inorganic phosphate export by the retrovirus receptor XPR1 in metazoans. Cell Rep. 2013, 3, 1866–1873. [Google Scholar] [CrossRef] [PubMed]
  235. Legati, A.; Giovannini, D.; Nicolas, G.; López-Sánchez, U.; Quintáns, B.; Oliveira, J.R.; Sears, R.L.; Ramos, E.M.; Spiteri, E.; Sobrido, M.J.; et al. Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export. Nat. Genet. 2015, 47, 579–581. [Google Scholar] [CrossRef]
  236. Beck-Cormier, S.; Lelliott, C.J.; Logan, J.G.; Lafont, D.T.; Merametdjian, L.; Leitch, V.D.; Butterfield, N.C.; Protheroe, H.J.; Croucher, P.I.; Baldock, P.A.; et al. Slc20a2, Encoding the Phosphate Transporter PiT2, Is an Important Genetic Determinant of Bone Quality and Strength. J. Bone Miner. Res. 2019, 34, 1101–1114. [Google Scholar] [CrossRef]
  237. Tsai, J.Y.; Chu, C.H.; Lin, M.G.; Chou, Y.H.; Hong, R.Y.; Yen, C.Y.; Hsiao, C.D.; Sun, Y.J. Structure of the sodium-dependent phosphate transporter reveals insights into human solute carrier SLC20. Sci. Adv. 2020, 6, eabb4024. [Google Scholar] [CrossRef]
  238. Villa-Bellosta, R.; Ravera, S.; Sorribas, V.; Stange, G.; Levi, M.; Murer, H.; Biber, J.; Forster, I.C. The Na+-Pi cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary Pi. Am. J. Physiol. Ren. Physiol. 2009, 296, F691–F699. [Google Scholar] [CrossRef]
  239. Jonsson, A.L.M.; Hernando, N.; Knöpfel, T.; Mogensen, S.; Bendstrup, E.; Hilberg, O.; Christensen, J.H.; Simonsen, U.; Wagner, C.A. Impaired phosphate transport in SLC34A2 variants in patients with pulmonary alveolar microlithiasis. Hum. Genom. 2022, 16, 13. [Google Scholar] [CrossRef]
  240. Jonsson, A.L.M.; Hilberg, O.; Simonsen, U.; Christensen, J.H.; Bendstrup, E. New insights in the genetic variant spectrum of SLC34A2 in pulmonary alveolar microlithiasis; a systematic review. Orphanet. J. Rare Dis. 2023, 18, 130. [Google Scholar] [CrossRef] [PubMed]
  241. Miyazaki, Y.; Sakai, H.; Shibata, Y.; Shibata, M.; Mataki, S.; Kato, Y. Expression and localization of ferritin mRNA in ameloblasts of rat incisor. Arch. Oral Biol. 1998, 43, 367–378. [Google Scholar] [CrossRef]
  242. Wen, X.; Paine, M.L. Iron deposition and ferritin heavy chain (Fth) localization in rodent teeth. BMC Res. Notes 2013, 6, 1. [Google Scholar] [CrossRef] [PubMed]
  243. Takano, Y.; Ozawa, H. Cytochemical studies on the ferritin-containing vesicles of the rat incisor ameloblasts with special reference to the acid phosphatase activity. Calcif. Tissue Int. 1981, 33, 51–55. [Google Scholar] [CrossRef] [PubMed]
  244. Sukseree, S.; Schwarze, U.Y.; Gruber, R.; Gruber, F.; Quiles Del Rey, M.; Mancias, J.D.; Bartlett, J.D.; Tschachler, E.; Eckhart, L. ATG7 is essential for secretion of iron from ameloblasts and normal growth of murine incisors during aging. Autophagy 2020, 16, 1851–1857. [Google Scholar] [CrossRef] [PubMed]
  245. Shieh, J.T.; Tintos-Hernández, J.A.; Murali, C.N.; Penon-Portmann, M.; Flores-Mendez, M.; Santana, A.; Bulos, J.A.; Du, K.; Dupuis, L.; Damseh, N.; et al. Heterozygous nonsense variants in the ferritin heavy-chain gene FTH1 cause a neuroferritinopathy. HGG Adv. 2023, 4, 100236. [Google Scholar] [PubMed]
  246. Pajor, K.; Pajchel, L.; Kolmas, J. Hydroxyapatite and Fluorapatite in Conservative Dentistry and Oral Implantology—A Review. Materials 2019, 12, 2683. [Google Scholar] [CrossRef] [PubMed]
  247. Simmer, J.P.; Hardy, N.C.; Chinoy, A.F.; Bartlett, J.D.; Hu, J.C. How Fluoride Protects Dental Enamel from Demineralization. J. Int. Soc. Prev. Community Dent. 2020, 10, 134–141. [Google Scholar] [CrossRef]
  248. Leroy, N.; Bres, E. Structure and substitutions in fluorapatite. Eur. Cell Mater. 2001, 2, 36–48. [Google Scholar] [CrossRef]
  249. Weatherell, J.A.; Robinson, C.; Hallsworth, A.S. Changes in the fluoride concentration of the labial enamel surface with age. Caries Res. 1972, 6, 312–324. [Google Scholar] [CrossRef]
  250. Kyllonen, M.S.; Parkkila, S.; Rajaniemi, H.; Waheed, A.; Grubb, J.H.; Shah, G.N.; Sly, W.S.; Kaunisto, K. Localization of carbonic anhydrase XII to the basolateral membrane of H+-secreting cells of mouse and rat kidney. J. Histochem. Cytochem. 2003, 51, 1217–1224. [Google Scholar] [CrossRef]
  251. Yin, K.; Lei, Y.; Wen, X.; Lacruz, R.S.; Soleimani, M.; Kurtz, I.; Snead, M.L.; White, S.N.; Paine, M.L. SLC26A Gene Family Participate in pH Regulation during Enamel Maturation. PLoS ONE 2015, 10, e0144703. [Google Scholar] [CrossRef] [PubMed]
  252. Bronckers, A.L.; Lyaruu, D.M.; Bervoets, T.J.; Medina, J.F.; DenBesten, P.; Richter, J.; Everts, V. Murine ameloblasts are immunonegative for Tcirg1, the v-H-ATPase subunit essential for the osteoclast plasma proton pump. Bone 2012, 50, 901–908. [Google Scholar] [CrossRef]
  253. Le, M.H.; Nakano, Y.; Abduweli Uyghurturk, D.; Zhu, L.; Den Besten, P.K. Fluoride Alters Klk4 Expression in Maturation Ameloblasts through Androgen and Progesterone Receptor Signaling. Front. Physiol. 2017, 8, 925. [Google Scholar] [CrossRef]
  254. Ji, M.; Xiao, L.; Xu, L.; Huang, S.; Zhang, D. How pH is regulated during amelogenesis in dental fluorosis. Exp. Ther. Med. 2018, 16, 3759–3765. [Google Scholar] [CrossRef]
  255. Schnetkamp, P.P. Na-Ca or Na-Ca-K exchange in rod photoreceptors. Prog. Biophys. Mol. Biol. 1989, 54, 1–29. [Google Scholar] [CrossRef] [PubMed]
  256. Szerencsei, R.T.; Prinsen, C.F.; Schnetkamp, P.P. Stoichiometry of the retinal cone Na/Ca-K exchanger heterologously expressed in insect cells: Comparison with the bovine heart Na/Ca exchanger. Biochemistry 2001, 40, 6009–6015. [Google Scholar] [CrossRef] [PubMed]
  257. Gordon, L.M.; Cohen, M.J.; MacRenaris, K.W.; Pasteris, J.D.; Seda, T.; Joester, D. Dental materials. Amorphous intergranular phases control the properties of rodent tooth enamel. Science 2015, 347, 746–750. [Google Scholar] [CrossRef]
  258. Hoylaerts, M.F.; Van Kerckhoven, S.; Kiffer-Moreira, T.; Sheen, C.; Narisawa, S.; Millán, J.L. Functional significance of calcium binding to tissue-nonspecific alkaline phosphatase. PLoS ONE 2015, 10, e0119874. [Google Scholar] [CrossRef] [PubMed]
  259. Irving, J.T. The influence of diets low in magnesium upon the histological appearance of the incisor tooth of the rat. J. Physiol. 1940, 99, 8–17. [Google Scholar] [CrossRef] [PubMed]
  260. Takano, Y.; Ozawa, H.; Crenshaw, M.A. Ca-ATPase and ALPase activities at the initial calcification sites of dentin and enamel in the rat incisor. Cell Tissue Res. 1986, 243, 91–99. [Google Scholar] [CrossRef]
  261. Klimuszko, E.; Orywal, K.; Sierpinska, T.; Sidun, J.; Golebiewska, M. Evaluation of calcium and magnesium contents in tooth enamel without any pathological changes: In vitro preliminary study. Odontology 2018, 106, 369–376. [Google Scholar] [CrossRef]
  262. Robinson, C.; Weatherell, J.A.; Hallsworth, A.S. Distribution of magnesium in mature human enamel. Caries Res. 1981, 15, 70–77. [Google Scholar] [CrossRef]
  263. Bystrov, V.S.; Paramonova, E.V.; Avakyan, L.A.; Eremina, N.V.; Makarova, S.V.; Bulina, N.V. Effect of Magnesium Substitution on Structural Features and Properties of Hydroxyapatite. Materials 2023, 16, 5945. [Google Scholar] [CrossRef] [PubMed]
  264. Gordon, L.M.; Joester, D. Mapping residual organics and carbonate at grain boundaries and the amorphous interphase in mouse incisor enamel. Front. Physiol. 2015, 6, 57. [Google Scholar] [CrossRef]
  265. Beniash, E.; Metzler, R.A.; Lam, R.S.; Gilbert, P.U. Transient amorphous calcium phosphate in forming enamel. J. Struct. Biol. 2009, 166, 133–143. [Google Scholar] [CrossRef]
  266. Xu, J.; Shi, H.; Luo, J.; Yao, H.; Wang, P.; Li, Z.; Wei, J. Advanced materials for enamel remineralization. Front. Bioeng. Biotechnol. 2022, 10, 985881. [Google Scholar] [CrossRef]
  267. Lale, S.; Solak, H.; Hınçal, E.; Vahdettin, L. In Vitro Comparison of Fluoride, Magnesium, and Calcium Phosphate Materials on Prevention of White Spot Lesions around Orthodontic Brackets. Biomed. Res. Int. 2020, 2020, 1989817. [Google Scholar] [CrossRef]
  268. McKee, M.D.; Zerounian, C.; Martineau-Doizé, B.; Warshawsky, H. Specific binding sites for transferrin on ameloblasts of the enamel maturation zone in the rat incisor. Anat. Rec. 1987, 218, 123–127. [Google Scholar] [CrossRef]
  269. Stein, G.; Boyle, P.E. Pigmentation of the enamel of albino rat incisor teeth. Arch. Oral Biol. 1959, 1, 97–105. [Google Scholar] [CrossRef] [PubMed]
  270. Yanagawa, T.; Itoh, K.; Uwayama, J.; Shibata, Y.; Yamaguchi, A.; Sano, T.; Ishii, T.; Yoshida, H.; Yamamoto, M. Nrf2 deficiency causes tooth decolourization due to iron transport disorder in enamel organ. Genes Cells 2004, 9, 641–651. [Google Scholar] [CrossRef] [PubMed]
  271. Srot, V.; Houari, S.; Kapun, G.; Bussmann, B.; Predel, F.; Pokorny, B.; Bužan, E.; Salzberger, U.; Fenk, B.; Kelsch, M.; et al. Ingenious Architecture and Coloration Generation in Enamel of Rodent Teeth. ACS Nano 2024, 18, 11270–11283. [Google Scholar] [CrossRef]
  272. Smith, T.; Codrea, V. Red Iron-Pigmented Tooth Enamel in a Multituberculate Mammal from the Late Cretaceous Transylvanian “Hateg Island”. PLoS ONE 2015, 10, e0132550. [Google Scholar] [CrossRef]
  273. Arosio, P.; Elia, L.; Poli, M. Ferritin, cellular iron storage and regulation. IUBMB Life 2017, 69, 414–422. [Google Scholar] [CrossRef]
  274. Imhof, T.; Rosenblatt, K.; Pryymachuk, G.; Weiland, D.; Noetzel, N.; Deschner, J.; Baris, O.R.; Kimoloi, S.; Koch, M.; Wiesner, R.J.; et al. Epithelial loss of mitochondrial oxidative phosphorylation leads to disturbed enamel and impaired dentin matrix formation in postnatal developed mouse incisor. Sci. Rep. 2020, 10, 22037. [Google Scholar] [CrossRef] [PubMed]
  275. Dirckx, N.; Zhang, Q.; Chu, E.Y.; Tower, R.J.; Li, Z.; Guo, S.; Yuan, S.; Khare, P.A.; Zhang, C.; Verardo, A.; et al. A specialized metabolic pathway partitions citrate in hydroxyapatite to impact mineralization of bones and teeth. Proc. Natl. Acad. Sci. USA 2022, 119, e2212178119. [Google Scholar] [CrossRef] [PubMed]
  276. Ruiz-Agudo, E.; Ruiz-Agudo, C.; Di Lorenzo, F.; Alvarez-Lloret, P.; Ibañez-Velasco, A.; Rodriguez-Navarro, C. Citrate Stabilizes Hydroxylapatite Precursors: Implications for Bone Mineralization. ACS Biomater. Sci. Eng. 2021, 7, 2346–2357. [Google Scholar] [CrossRef]
  277. Chen, J.; Xian, G.; Xiao, Z.; Ge, F.; Yuan, S.; Li, B.; Liang, X.; Cai, Z.; Zhang, N.; Zhang, L.; et al. Biomineralization-inspired scaffolds using citrate-based polymers to stabilize amorphous calcium phosphate promote osteogenesis and angiogenesis for bone defect repair. Bioact. Mater. 2025, 56, 260–276. [Google Scholar] [CrossRef] [PubMed]
  278. McKee, M.D.; Warshawsky, H.; Nanci, A. Cyclical incorporation of 33P into rat incisor enamel in vivo as visualized by whole-mount radioautography. Arch. Oral Biol. 1989, 34, 989–993. [Google Scholar] [CrossRef]
  279. Smith, C.E.; McKee, M.D.; Nanci, A. Cyclic induction and rapid movement of sequential waves of new smooth-ended ameloblast modulation bands in rat incisors as visualized by polychrome fluorescent labeling and GBHA-staining of maturing enamel. Adv. Dent. Res. 1987, 1, 162–175. [Google Scholar] [CrossRef]
  280. McKee, M.D. Use of backscattered electron imaging on developed radioautographic emulsions: Application to viewing rat incisor enamel maturation pattern following 45calcium injection. J. Electron. Microsc. Tech. 1987, 5, 357–365. [Google Scholar] [CrossRef]
  281. Robinson, C.; Hiller, C.R.; Weatherell, J.A. Uptake of 32P-labelled phosphate into developing rat incisor enamel. Calcif. Tissue Res. 1974, 15, 143–152. [Google Scholar] [CrossRef]
  282. Hiller, C.R.; Robinson, C.; Weatherell, J.A. Variations in the composition of developing rat incisor enamel. Calcif. Tissue Res. 1975, 18, 1–12. [Google Scholar] [CrossRef]
  283. Crouthamel, M.H.; Lau, W.L.; Leaf, E.M.; Chavkin, N.W.; Wallingford, M.C.; Peterson, D.F.; Li, X.; Liu, Y.; Chin, M.T.; Levi, M.; et al. Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: Redundant roles for PiT-1 and PiT-2. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 2625–2632. [Google Scholar] [CrossRef] [PubMed]
  284. Bottger, P.; Hede, S.E.; Grunnet, M.; Høyer, B.; Klaerke, D.A.; Pedersen, L. Characterization of transport mechanisms and determinants critical for Na+-dependent Pi symport of the PiT family paralogs human PiT1 and PiT2. Am. J. Physiol. Cell Physiol. 2006, 291, C1377–C1387. [Google Scholar] [CrossRef] [PubMed]
  285. Chen, L.; He, J.; Wang, M.; She, J. Structure and function of human XPR1 in phosphate export. Nat. Commun. 2025, 16, 2983. [Google Scholar] [CrossRef]
  286. Ravera, S.; Virkki, L.V.; Murer, H.; Forster, I.C. Deciphering PiT transport kinetics and substrate specificity using electrophysiology and flux measurements. Am. J. Physiol. Cell Physiol. 2007, 293, C606–C620. [Google Scholar] [CrossRef]
  287. Zhao, D.; Vaziri Sani, F.; Nilsson, J.; Rodenburg, M.; Stocking, C.; Linde, A.; Gritli-Linde, A. Expression of Pit2 sodium-phosphate cotransporter during murine odontogenesis is developmentally regulated. Eur. J. Oral Sci. 2006, 114, 517–523. [Google Scholar] [CrossRef]
  288. Virkki, L.V.; Biber, J.; Murer, H.; Forster, I.C. Phosphate transporters: A tale of two solute carrier families. Am. J. Physiol. Renal. Physiol. 2007, 293, F643–F654. [Google Scholar] [CrossRef] [PubMed]
  289. Wagner, C.A. Pharmacology of Mammalian Na+-Dependent Transporters of Inorganic Phosphate. Handb. Exp. Pharmacol. 2024, 283, 285–317. [Google Scholar]
  290. Kavanaugh, M.P.; Miller, D.G.; Zhang, W.; Law, W.; Kozak, S.L.; Kabat, D.; Miller, A.D. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. USA 1994, 91, 7071–7075. [Google Scholar] [CrossRef]
  291. Marks, J.; Debnam, E.S.; Unwin, R.J. Phosphate homeostasis and the renal-gastrointestinal axis. Am. J. Physiol. Renal. Physiol. 2010, 299, F285–F296. [Google Scholar] [CrossRef] [PubMed]
  292. Fang, R.; Xiang, Z.; Cao, M.; He, J. Different phosphate transport in the duodenum and jejunum of chicken response to dietary phosphate adaptation. Asian-Australas J. Anim. Sci. 2012, 25, 1457–1465. [Google Scholar] [CrossRef]
  293. Graham, C.; Nalbant, P.; Schölermann, B.; Hentschel, H.; Kinne, R.K.; Werner, A. Characterization of a type IIb sodium-phosphate cotransporter from zebrafish (Danio rerio) kidney. Am. J. Physiol. Renal. Physiol. 2003, 284, F727–F736. [Google Scholar] [CrossRef]
  294. Stauber, A.; Radanovic, T.; Stange, G.; Murer, H.; Wagner, C.A.; Biber, J. Regulation of intestinal phosphate transport. II. Metabolic acidosis stimulates Na+-dependent phosphate absorption and expression of the Na+-P(i) cotransporter NaPi-IIb in small intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288, G501–G506. [Google Scholar] [CrossRef]
  295. Zuo, P.; Wang, W.; Dai, Z.; Zheng, J.; Yu, S.; Wang, G.; Yin, Y.; Liang, L.; Yin, Y. Synergistic activation of the human phosphate exporter XPR1 by KIDINS220 and inositol pyrophosphate. Nat. Commun. 2025, 16, 2879. [Google Scholar] [CrossRef] [PubMed]
  296. Knopfel, T.; Pastor-Arroyo, E.M.; Schnitzbauer, U.; Kratschmar, D.V.; Odermatt, A.; Pellegrini, G.; Hernando, N.; Wagner, C.A. The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restriction. Sci. Rep. 2017, 7, 11018. [Google Scholar] [CrossRef]
  297. Bai, Y.; Yu, Z.; Ackerman, L.; Zhang, Y.; Bonde, J.; Li, W.; Cheng, Y.; Habelitz, S. Protein nanoribbons template enamel mineralization. Proc. Natl. Acad. Sci. USA 2020, 117, 19201–19208. [Google Scholar] [CrossRef] [PubMed]
  298. Boonrungsiman, S.; Gentleman, E.; Carzaniga, R.; Evans, N.D.; McComb, D.W.; Porter, A.E.; Stevens, M.M. The role of intracellular calcium phosphate in osteoblast-mediated bone apatite formation. Proc. Natl. Acad. Sci. USA 2012, 109, 14170–14175. [Google Scholar] [CrossRef]
  299. McIntyre, B.; Solesio, M.E. Mitochondrial inorganic polyphosphate (polyP): The missing link of mammalian bioenergetics. Neural Regen. Res. 2021, 16, 2227–2228. [Google Scholar] [CrossRef] [PubMed]
  300. Docampo, R.; Moreno, S.N. Acidocalcisomes. Cell Calcium 2011, 50, 113–119. [Google Scholar] [CrossRef]
  301. Da Costa, R.T.; Urquiza, P.; Perez, M.M.; Du, Y.; Khong, M.L.; Zheng, H.; Guitart-Mampel, M.; Elustondo, P.A.; Scoma, E.R.; Hambardikar, V.; et al. Mitochondrial inorganic polyphosphate is required to maintain proteostasis within the organelle. Front. Cell Dev. Biol. 2024, 12, 1423208. [Google Scholar] [CrossRef]
  302. Muller, W.E.G.; Schroder, H.C.; Wang, X. Inorganic Polyphosphates As Storage for and Generator of Metabolic Energy in the Extracellular Matrix. Chem. Rev. 2019, 119, 12337–12374. [Google Scholar] [CrossRef]
  303. Omelon, S.J.; Grynpas, M.D. Relationships between polyphosphate chemistry, biochemistry and apatite biomineralization. Chem. Rev. 2008, 108, 4694–4715. [Google Scholar] [CrossRef] [PubMed]
  304. Muller, W.E.G.; Ackermann, M.; Al-Nawas, B.; Righesso, L.A.R.; Muñoz-Espí, R.; Tolba, E.; Neufurth, M.; Schröder, H.C.; Wang, X. Amplified morphogenetic and bone forming activity of amorphous versus crystalline calcium phosphate/polyphosphate. Acta Biomater. 2020, 118, 233–247. [Google Scholar] [CrossRef]
  305. McGaughey, C. Binding of polyphosphates and phosphonates to hydroxyapatite, subsequent hydrolysis, phosphate exchange and effects on demineralization, mineralization and microcrystal aggregation. Caries Res. 1983, 17, 229–241. [Google Scholar] [CrossRef]
  306. McGaughey, C.; Stowell, E.C. Effects of polyphosphates on the solubility and mineralization of HA: Relevance to a rationale for anticaries activity. J. Dent. Res. 1977, 56, 579–587. [Google Scholar] [CrossRef]
  307. Hotton, D.; Mauro, N.; Lézot, F.; Forest, N.; Berdal, A. Differential expression and activity of tissue-nonspecific alkaline phosphatase (TNAP) in rat odontogenic cells in vivo. J. Histochem. Cytochem. 1999, 47, 1541–1552. [Google Scholar] [CrossRef]
  308. Lorenz, B.; Schroder, H.C. Mammalian intestinal alkaline phosphatase acts as highly active exopolyphosphatase. Biochim. Biophys. Acta 2001, 1547, 254–261. [Google Scholar] [CrossRef]
  309. Millan, J.L. Alkaline Phosphatases: Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal 2006, 2, 335–341. [Google Scholar] [CrossRef]
  310. Hessle, L.; Johnson, K.A.; Anderson, H.C.; Narisawa, S.; Sali, A.; Goding, J.W.; Terkeltaub, R.; Millan, J.L. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc. Natl. Acad. Sci. USA 2002, 99, 9445–9449. [Google Scholar] [CrossRef]
  311. Lowe, D.; Sanvictores, T.; Zubair, M.; John, S. Alkaline Phosphatase; StatPearls: Treasure Island, FL, USA, 2025. [Google Scholar]
  312. Anderson, H.C. Matrix vesicles and calcification. Curr. Rheumatol. Rep. 2003, 5, 222–226. [Google Scholar] [CrossRef] [PubMed]
  313. Anderson, H.C.; Sipe, J.B.; Hessle, L.; Dhanyamraju, R.; Atti, E.; Camacho, N.P.; Millán, J.L.; Dhamyamraju, R. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am. J. Pathol. 2004, 164, 841–847. [Google Scholar] [CrossRef] [PubMed]
  314. Hoac, B.; Kiffer-Moreira, T.; Millán, J.L.; McKee, M.D. Polyphosphates inhibit extracellular matrix mineralization in MC3T3-E1 osteoblast cultures. Bone 2013, 53, 478–486. [Google Scholar] [CrossRef]
  315. Da Costa, R.T.; Nichenko, A.; Perez, M.M.; Tokarska-Schlattner, M.; Kavehmoghaddam, S.; Hambardikar, V.; Scoma, E.R.; Seifert, E.L.; Schlattner, U.; Drake, J.C.; et al. Mammalian mitochondrial inorganic polyphosphate (polyP) and cell signaling: Crosstalk between polyP and the activity of AMPK. Mol. Metab. 2025, 91, 102077. [Google Scholar] [CrossRef]
  316. Schoeppe, R.; Waldmann, M.; Jessen, H.J.; Renné, T. An Update on Polyphosphate In Vivo Activities. Biomolecules 2024, 14, 937. [Google Scholar] [CrossRef]
  317. Hasegawa, T.; Hongo, H.; Yamamoto, T.; Abe, M.; Yoshino, H.; Haraguchi-Kitakamae, M.; Ishizu, H.; Shimizu, T.; Iwasaki, N.; Amizuka, N. Matrix Vesicle-Mediated Mineralization and Osteocytic Regulation of Bone Mineralization. Int. J. Mol. Sci. 2022, 23, 9941. [Google Scholar] [CrossRef]
  318. Ansari, S.; de Wildt, B.W.M.; Vis, M.A.M.; de Korte, C.E.; Ito, K.; Hofmann, S.; Yuana, Y. Matrix Vesicles: Role in Bone Mineralization and Potential Use as Therapeutics. Pharmaceuticals 2021, 14, 289. [Google Scholar] [CrossRef] [PubMed]
  319. Li, L.; Khong, M.L.; Lui, E.L.H.; Mebarek, S.; Magne, D.; Buchet, R.; Tanner, J.A. Long-chain polyphosphate in osteoblast matrix vesicles: Enrichment and inhibition of mineralization. Biochim. Biophys. Acta Gen. Subj. 2019, 1863, 199–209. [Google Scholar] [CrossRef]
  320. Kus, F.; Smolenski, R.T.; Tomczyk, M. Inorganic Polyphosphate-Regulator of Cellular Metabolism in Homeostasis and Disease. Biomedicines 2022, 10, 913. [Google Scholar] [CrossRef]
  321. Millan, J.L. The role of phosphatases in the initiation of skeletal mineralization. Calcif. Tissue Int. 2013, 93, 299–306. [Google Scholar] [CrossRef]
  322. Walker, V. The Intricacies of Renal Phosphate Reabsorption—An Overview. Int. J. Mol. Sci. 2024, 25, 4684. [Google Scholar] [CrossRef] [PubMed]
  323. Schlingmann, K.P.; Ruminska, J.; Kaufmann, M.; Dursun, I.; Patti, M.; Kranz, B.; Pronicka, E.; Ciara, E.; Akcay, T.; Bulus, D.; et al. Autosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile Hypercalcemia. J. Am. Soc. Nephrol. 2016, 27, 604–614. [Google Scholar] [PubMed]
  324. Yu, Y.; Sanderson, S.R.; Reyes, M.; Sharma, A.; Dunbar, N.; Srivastava, T.; Jüppner, H.; Bergwitz, C. Novel NaPi-IIc mutations causing HHRH and idiopathic hypercalciuria in several unrelated families: Long-term follow-up in one kindred. Bone 2012, 50, 1100–1106. [Google Scholar] [CrossRef] [PubMed]
  325. Clayton, D.; Chavez, M.B.; Tan, M.H.; Kolli, T.N.; Giovani, P.A.; Hammersmith, K.J.; Bowden, S.A.; Foster, B.L. Mineralization Defects in the Primary Dentition Associated With X-Linked Hypophosphatemic Rickets. JBMR Plus 2021, 5, e10463. [Google Scholar]
  326. Arhar, A.; Pavlic, A.; Hocevar, L. Characteristics of oral health of patients with X-linked hypophosphatemia: Case reports and literature review. BDJ Open 2024, 10, 42. [Google Scholar] [CrossRef] [PubMed]
  327. Abdullah, A.; Wuersching, S.N.; Kollmuss, M.; Poxleitner, P.; Dewenter, I.; Brandenburg, L.S.; Steybe, D.; Fegg, F.N.; Smolka, W.; Otto, S.; et al. X-Linked Hypophosphatemia: Does Targeted Therapy Modify Dental Impairment? J. Clin. Med. 2023, 12, 7546. [Google Scholar] [CrossRef]
  328. Segawa, H.; Onitsuka, A.; Furutani, J.; Kaneko, I.; Aranami, F.; Matsumoto, N.; Tomoe, Y.; Kuwahata, M.; Ito, M.; Matsumoto, M.; et al. Npt2a and Npt2c in mice play distinct and synergistic roles in inorganic phosphate metabolism and skeletal development. Am. J. Physiol. Renal Physiol. 2009, 297, F671–F678. [Google Scholar] [CrossRef]
  329. Law, K.T.; Lee, C.K.; King, N.M.; Rabie, A.B. The relationship between eruption and length of mandibular incisors in young rats. Med. Sci. Monit. 2003, 9, BR47–BR53. [Google Scholar]
  330. McKee, M.D.; Martin, J.R.; Landis, W.J. Biophysical analyses of sequential bands of enamel related to ruffle-ended and smooth-ended maturation ameloblasts. J. Dent. Res. 1989, 68, 101–106. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Schematic showing an overview of amelogenesis from the inner enamel epithelium (IEE) to the maturation stage. From left to right, signals from odontoblasts induce the differentiation of IEE cells into pre-ameloblasts. This developmental phase, also referred to as the pre-secretory stage, is characterized by tightly regulated epithelial–mesenchymal interactions that culminate in the formation of secretory ameloblasts. Secretory ameloblasts develop a highly specialized apical extension, the Tomes’ process, and initiate secretion of the enamel extracellular matrix (depicted in blue, apical to the Tomes’ processes). The subsequent transition stage represents a brief but critical shift from matrix secretion to mineralization. Enamel matrix proteins are progressively removed and replaced by hydroxyapatite that assemble into the distinctive rod-interrod architecture (represented by black solid and dashed lines). A hallmark of the maturation stage is the alternation between two ameloblast morphologies, ruffle-ended and smooth-ended, visualized here as alternating groups of cells with ruffled versus smooth apical surfaces.
Figure 1. Schematic showing an overview of amelogenesis from the inner enamel epithelium (IEE) to the maturation stage. From left to right, signals from odontoblasts induce the differentiation of IEE cells into pre-ameloblasts. This developmental phase, also referred to as the pre-secretory stage, is characterized by tightly regulated epithelial–mesenchymal interactions that culminate in the formation of secretory ameloblasts. Secretory ameloblasts develop a highly specialized apical extension, the Tomes’ process, and initiate secretion of the enamel extracellular matrix (depicted in blue, apical to the Tomes’ processes). The subsequent transition stage represents a brief but critical shift from matrix secretion to mineralization. Enamel matrix proteins are progressively removed and replaced by hydroxyapatite that assemble into the distinctive rod-interrod architecture (represented by black solid and dashed lines). A hallmark of the maturation stage is the alternation between two ameloblast morphologies, ruffle-ended and smooth-ended, visualized here as alternating groups of cells with ruffled versus smooth apical surfaces.
Cells 14 01821 g001
Figure 2. Ion-transport machinery of an ameloblast at the enamel surface. At the basal membrane, NBCe1 loads bicarbonate, while Na+-K+-2Cl cotransporter (NKCC1) and the Na+/K+ pump (not shown explicitly) maintain driving gradients. A V-type H+-ATPase (proton pump) provides ATP-dependent proton extrusion. SOCE occurs where ORAI calcium release-activated calcium modulator 1 (ORAI1) in the plasma membrane is activated by Stromal interaction molecule 1 (STIM1) upon ER Ca2+ store depletion; ER Sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) reloads Ca2+, and Inositol 1,4,5-trisphosphate receptor (IP3R) releases Ca2+ from the ER. Cytosolic carbonic anhydrases (CA II/III) generate H+ and HCO3 from CO2 and H2O to fuel pH control. At the apical (enamel-facing) membrane, CFTR provides a Cl pathway that drives coupled SLC26A exchangers (e.g., A3/A4/A6) to secrete HCO3 into the enamel space. AE2 contributes additional Cl/HCO3 exchange for intracellular pH balance. Calcium is exported primarily by NCKX4 (1 Ca2+ + 1 K+ out for 4 Na+ in) with auxiliary NCX (3 Na+ in:1 Ca2+ out). TRPM7 permits Mg2+ entry from the matrix, whereas CNNM4 mediates Mg2+ efflux (coupled to Na+). An Na+/H+ exchanger (NHE) removes protons produced during crystal growth. Tight junctions between adjacent ameloblasts not only restrict paracellular flux but may similarly influence ion permeability, as shown in other epithelia where passive Ca2+ movement occurs through claudin-based channels.
Figure 2. Ion-transport machinery of an ameloblast at the enamel surface. At the basal membrane, NBCe1 loads bicarbonate, while Na+-K+-2Cl cotransporter (NKCC1) and the Na+/K+ pump (not shown explicitly) maintain driving gradients. A V-type H+-ATPase (proton pump) provides ATP-dependent proton extrusion. SOCE occurs where ORAI calcium release-activated calcium modulator 1 (ORAI1) in the plasma membrane is activated by Stromal interaction molecule 1 (STIM1) upon ER Ca2+ store depletion; ER Sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) reloads Ca2+, and Inositol 1,4,5-trisphosphate receptor (IP3R) releases Ca2+ from the ER. Cytosolic carbonic anhydrases (CA II/III) generate H+ and HCO3 from CO2 and H2O to fuel pH control. At the apical (enamel-facing) membrane, CFTR provides a Cl pathway that drives coupled SLC26A exchangers (e.g., A3/A4/A6) to secrete HCO3 into the enamel space. AE2 contributes additional Cl/HCO3 exchange for intracellular pH balance. Calcium is exported primarily by NCKX4 (1 Ca2+ + 1 K+ out for 4 Na+ in) with auxiliary NCX (3 Na+ in:1 Ca2+ out). TRPM7 permits Mg2+ entry from the matrix, whereas CNNM4 mediates Mg2+ efflux (coupled to Na+). An Na+/H+ exchanger (NHE) removes protons produced during crystal growth. Tight junctions between adjacent ameloblasts not only restrict paracellular flux but may similarly influence ion permeability, as shown in other epithelia where passive Ca2+ movement occurs through claudin-based channels.
Cells 14 01821 g002
Figure 3. Schematic representation of phosphate transporters in ameloblasts during the maturation stage of amelogenesis. During the maturation stage, ameloblasts alternate between ruffle-ended and smooth-ended morphologies, both of which are illustrated here. To avoid overcrowding, two transporters are shown on each cell rather than all four on a single ameloblast. The main phosphate transporters implicated in ameloblast function are highlighted. PiT1 on the basolateral side mediates sodium-dependent phosphate uptake from the blood/interstitial fluid, while NaPi-IIb at the apical side imports phosphate from the enamel matrix and XPR1 exports phosphate toward the enamel space. The number and type of ions transported by each channel are indicated in the schematic. Hydroxyapatite crystals in the enamel matrix are shown at the apical surface to indicate the site of mineralization.
Figure 3. Schematic representation of phosphate transporters in ameloblasts during the maturation stage of amelogenesis. During the maturation stage, ameloblasts alternate between ruffle-ended and smooth-ended morphologies, both of which are illustrated here. To avoid overcrowding, two transporters are shown on each cell rather than all four on a single ameloblast. The main phosphate transporters implicated in ameloblast function are highlighted. PiT1 on the basolateral side mediates sodium-dependent phosphate uptake from the blood/interstitial fluid, while NaPi-IIb at the apical side imports phosphate from the enamel matrix and XPR1 exports phosphate toward the enamel space. The number and type of ions transported by each channel are indicated in the schematic. Hydroxyapatite crystals in the enamel matrix are shown at the apical surface to indicate the site of mineralization.
Cells 14 01821 g003
Table 1. Ion Transporters and Regulators in Amelogenesis.
Table 1. Ion Transporters and Regulators in Amelogenesis.
Ion(s)Gene/ProteinIons TransportedFunction in AmeloblastsLocationStoichiometryDisease AssociationsKey References
Ca2+STIM1/STIM2 + ORAI1 (SOCE/CRAC)Ca2+ influx (store-operated)Basolateral SOCE that replenishes cytosolic and ER Ca2+ to support maturation-stage transport and apical effluxORAI1 at basolateral plasma membrane; STIM1/2 in ERChannel-mediated, non-stoichiometricLoss/impairment → hypomineralized, AI-like enamel (Stim1/2 cKO; ORAI perturbation); STIM1 mutations linked to AI in humans[101,173,186,202]
Ca2+ATP2A (SERCA)Ca2+ into ER (H+ countertransport)Refills ER Ca2+ stores; buffers cytosolic Ca2+ and terminates SOCEER membranes2 Ca2+ in:2–3 H+ out per ATPATP2A2 → Darier disease (skin); General Ca2+ imbalance; not AI-specific[101,173,203,204,205]
Ca2+SLC24A4 (NCKX4)Ca2+ efflux, Na+ in, K+ outMajor Ca2+ exporter during maturation; supports matrix mineralization and optimizes KLK4-mediated protein clearanceApical membrane of ruffle-ended ameloblastsElectrogenic 4 Na+ in:1 Ca2+ + 1 K+ outBiallelic SLC24A4 variants → autosomal-recessive hypomaturation AI[81,101,151,168,196,201]
Ca2+SLC8A1/3 (NCX1/3)Ca2+ efflux, Na+ influxSupplementary Ca2+ extrusion during maturation (minor vs. NCKX4)Apical (Tomes’ process); remains detectable during the maturation stage3 Na+ in:1 Ca2+ out (electrogenic)Not directly linked to AI[101,196,197,198,206]
Ca2+ATP2B1/4 (PMCA1/4)Ca2+ efflux, H+ counter-transportATP-driven clearance of cytosolic Ca2+; supports acid-base balance; complements NCKX4 during maturationBasolateral, with occasional reports of apical/apicolateral labeling1 Ca2+ out:2 H+ in per ATP (overall electroneutral)No direct AI; perturbation associates with hypomineralized enamel (e.g., Atp2b1a knockdown impairs tooth mineralization; PMCA4 reduced in Mmp20/ enamel)[198,199]
HCO3 (with Na+)SLC4A4 (NBCe1)Na+ + HCO3 influxBasolateral bicarbonate supplyBasolateral1 Na+ + 2–3 HCO3 inMutations → enamel hypoplasia[87,179,180,207,208]
HCO3/H+Carbonic anhydrases: CA2/CA6/CA12 (CA II/VI/XII)CO2 hydration → H+ + HCO3Local HCO3 generation to support apical HCO3 secretion and matrix pH control during maturationCA II cytosol (ameloblasts and papillary layer); CA VI secreted → enamel fluid; CA XII membrane/apicalEnzymatic (reversible; no fixed stoichiometry)CA II deficiency → enamel defects/hypoplasia[24,209,210,211]
HCO3/ClSLC4A2 (AE2)Cl/HCO3 exchangeBasolateral HCO3 extrusion and Cl uptake to support pH homeostasis and apical HCO3 secretionApical (secretory)/basolateral (maturation)1:1 (electroneutral)Slc4a2/Ae2 knockout → hypomineralized enamel, failed maturation[92,207,212]
HCO3/ClCFTR (CFTR)Cl and HCO3 (HCO3-permeable anion channel)Apical anion conductance that permits Cl efflux and supports HCO3 secretion to neutralize protons during maturation; provides Cl recycling for apical Cl/HCO3 exchangers (e.g., SLC26 family)Apical membrane of maturation-stage ameloblastsChannel; electrodiffusive (no fixed stoichiometry)Loss-of-function (cystic fibrosis) → hypomineralized, acidic maturation bands; altered Cl/Ca2+ content in Cftr-null enamel[1,169,177,213]
HCO3/Cl SLC26A1 (Sat1)/A3 (Dra)/A4 (pendrin)/A6 (Pat1)/A7 (Sut2) Cl/HCO3 exchange (CFTR-coupled)Apical HCO3 secretion for matrix neutralization and protein clearance (maturation)Apical (A1, A3, A4 and A6); apical and supranuclear (A4); apical, partly subapical, cytoplasmic (A7)Mostly 1:1; A6 often 1 Cl:2 HCO3No direct enamel disorder; A4→Pendred (systemic); Slc26a7 deletion delays enamel (rat)[214,215,216,217]
H+ATP6V (V-ATPase; e.g., ATP6V1B1/ATP6V0A4)H+ efflux (proton pump)Apical acidification during ruffle-ended phases; endo-lysosomal acidification supporting matrix protein resorption; a3 disruption impacts ameloblasts/enamel (mouse)Apical membrane of ruffle-ended ameloblasts; endosomal/lysosomal membranesATP-driven (H+/ATP ≈ 2–4; electrogenic)autosomal recessive distal renal tubular acidosis (dRTA) from ATP6V1B1/ATP6V0A4 mutations; impaired acidification can disrupt matrix processing[4,36,218,219,220]
H+/Na+SLC9A1 (NHE1)Na+/H+ exchange (H+ efflux, Na+ influx)Basolateral pHi recovery/stabilization after acid loads; supports vectorial HCO3 secretion (via CA-generated HCO3 + H+ extrusion)Basolateral~1 Na+:1 H+ (electroneutral)Not directly linked to AI[1,177,212,221,222]
Na+/K+ATP1A1/ATP1B1 (Na+/K+-ATPase α1/β1)Na+ out, K+ inMaintains the Na+ gradient that powers secondary transport (NBCe1, NCKX/NCX, NHE1; supports CFTR/SLC26 circuits and cell-volume control)Cytoplasmic and Basolateral membrane of secretory and maturation ameloblasts (also papillary layer)3 Na+ out:2 K+ in (ATP)Essential for epithelial transport; no enamel-specific AI link[1,170,174]
Na+/K+/ClSLC12A2 (NKCC1)Na+, K+, 2 Cl inOsmolyte control and Cl supply from support layers to sustain ameloblast ion transport; regulatory volume functionPapillary layer and outer enamel epithelium (non-ameloblast support cells; SI/SR in earlier stage context)1 Na+ + 1 K+ + 2 Cl inNkcc1/: late-maturation ameloblasts disorganized/shorter and ~10% lower enamel mineral density; ↑ Connexin 43 (Cx43)/NBCe1/SLC26A3/A6 compensation (hypomineralization)[1,68,175]
K+KCNJ15 (Kir4.2)K+ recyclingK+ uptake from enamel fluid; helps stabilize apical membrane potential during ruffle-ended phases; coordinates with NCKX4/Na+ handlingApical border of ruffle-ended ameloblasts and cytosol of SA (reduced in smooth-ended; mislocalized with fluorosis/Wdr72 loss)Channel (rectifier; non-stoichiometric)No direct AI link; apical localization is reduced in fluorosis[168,170]
Mg2+CNNM4Mg2+ efflux (Na+-linked)Prevents intracellular Mg2+ buildup; supports proper crystal chemistry and maturationBasolateral membrane of maturation ameloblastsNa+-linked; stoichiometry not established in ameloblasts (2 Na+:1 Mg2+ reported in other cells)Biallelic CNNM4 Mutations → Jalili syndrome (cone-rod dystrophy + AI) [1,184,223,224]
Mg2+TRPM7Divalent-permeable channel (Mg2+ influx; also Ca2+)Maintains Mg2+ homeostasis; supplies Mg2+ needed for TNAP/ALPL activity; also contributes to/positively modulates Ca2+ entryPlasma membrane of maturation ameloblasts (evident in HAT-7 and mouse incisor; basolateral enrichment proposed)Channel (non-stoichiometric)TRPM7 kinase-dead or enamel-epithelium cKO → hypomineralized/hypoplastic enamel; reduced ALPase activity partly rescued by Mg2+[185,225,226,227,228]
Citrate (Cit3−)SLC13A5 (NaCT)Na+-coupled citrate influxSupplies intracellular citrate for metabolism and incorporation at the mineral front; modulates crystal surface chemistry/toughness and transiently chelates Ca2+ during maturationBasolateral (ameloblasts); papillary layer/support cellsElectrogenic ~3–4 Na+:1 citrate (pH-dependent)Biallelic SLC13A5 variants → developmental and epileptic encephalopathy (DEE25); reported enamel hypoplasia/thin enamel[229,230,231]
PO43−ALPL (TNAP)Liberates PO43− by hydrolyzing PPi/other phosphomonoestersProvides local orthophosphate for enamel mineral growth; supports matrix pH controlStratum intermedium (high); also, maturation-stage ameloblastsEnzyme (no fixed stoichiometry)Hypophosphatasia
(ALPL) → enamel defects/hypomineralization
[1,67,232,233]
PO43−SLC53A1 (XPR1)Pi efflux (non–Na+-coupled, IP6/InsP7-regulated)Exports intracellular Pi toward the enamel space; coordinates with TNAP (PPi→Pi) and NaPi-IIb uptake to maintain matrix Pi/PPi balanceApical (Tomes’ process, putative)Not fully established; electrogenic (non-stoichiometric)Biallelic XPR1 variants → primary familial brain calcification (PFBC/IBGC6); no enamel-specific phenotype[11,233,234,235]
PO43−SLC20A1/2 (PiT1/2)Na+-coupled Pi influxPi import into ameloblasts (PiT1); PiT2 prominent in support layers → paracrine Pi supplyPiT1: ameloblasts (likely basolateral); PiT2: stratum intermedium/sub-odontoblastic layer2 Na+:1 Pi (in)No firm AI link; Slc20a2/ → dentin defects, enamel largely preserved[1,9,236,237,238]
HPO42−SLC34A2 (NaPi-IIb)Na+-coupled Pi influxPi import to support mineral growthApical and nuclear in secretory; apical, and cytoplasmic in maturation3 Na+:1 HPO42− (in)Variants → pulmonary alveolar microlithiasis (PAM); no direct AI link[9,10,29,239,240]
FeFerritin (FTH1)Iron storage (Fe3+ mineral core)Sequesters Fe to limit oxidative stress; transient reservoir for Fe later deposited into enamel surface (rodent incisors)Cytosol and ferritin-containing vesicles of late-maturation ameloblasts; papillary layerNanocage; up to ~4500 Fe atomsDisrupted iron handling (e.g., ATG7 loss) → removes the iron deposit that normally pigments rodent incisors and can impair enamel, not classified as AI (hereditary)[241,242,243,244,245]
F(Fluoride incorporation)F substitution for OH in apatiteForms fluorapatite; lowers crystal solubility and increases acid resistanceEnamel mineral lattice (surface-enriched)1 F:1 OH (Ca10(PO4)6(OH)2 → Ca10(PO4)6F2)Excess during development → fluorosis; low exposure → ↑ caries risk[154,246,247,248,249]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zarinfar, M.; Aghazadeh, M.; Bapat, R.A.; Ji, Y.; Paine, M.L. Enamel Maturation as a Systems Physiology: Ion Transport and Pi Flux. Cells 2025, 14, 1821. https://doi.org/10.3390/cells14221821

AMA Style

Zarinfar M, Aghazadeh M, Bapat RA, Ji Y, Paine ML. Enamel Maturation as a Systems Physiology: Ion Transport and Pi Flux. Cells. 2025; 14(22):1821. https://doi.org/10.3390/cells14221821

Chicago/Turabian Style

Zarinfar, Mehrnaz, Marziyeh Aghazadeh, Rucha Arun Bapat, Yanbin Ji, and Michael L. Paine. 2025. "Enamel Maturation as a Systems Physiology: Ion Transport and Pi Flux" Cells 14, no. 22: 1821. https://doi.org/10.3390/cells14221821

APA Style

Zarinfar, M., Aghazadeh, M., Bapat, R. A., Ji, Y., & Paine, M. L. (2025). Enamel Maturation as a Systems Physiology: Ion Transport and Pi Flux. Cells, 14(22), 1821. https://doi.org/10.3390/cells14221821

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop